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ABSTRACT  
 
MOLECULAR INSIGHTS INTO THE DISTINCT MECHANISMS REGULATING 
THE TLR4 MEDIATED ACTIVATION, SHUT DOWN, AND ENDOTOXIN 
TOLERANCE OF IL1B AND TNF 
 
 
By 
Juraj Adamik 
May 2013 
 
Dissertation supervised by Philip. E. Auron, Ph.D.  
The first wave of the inducible gene network up-regulated by pathogen-stimulated 
mononuclear cells encodes a variety of effector proteins with pleitropic biological 
activities. This class of primary immediate early (IE) genes codes for potent pro-
inflammatory cytokines and chemokines that play a prominent role during the 
manifestation of inflammatory response. In an attempt to better understand induction 
mechanisms for such genes, I have focused on those coding for human interleukin-1 
(IL1B) and tumor necrosis factor  (TNF), which exhibit both transient IE induction as 
well as cell-type restriction. Employing a combined approach using cell lines and primary 
cells, reporter transient transfection, chromatin conformational capture and 
immunoprecipitation, evaluation of transcript integrity, ectopic expression in a non-
competent cell type, and comparison to mouse orthologs, I have determined that a 
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complex array of mechanisms interplay in order to distinctly regulate the Toll-like 
receptor (TLR) signaling-dependent induction of these two important pro-inflammatory 
genes whose deregulation provides the etiology for numerous diseases. Prior to induction, 
TNF exhibited pre-bound TATA Binding Protein (TBP) and paused RNA Polymerase II 
(Pol II), which are the hallmarks of poised IE genes. In contrast, IL1B is stringently 
regulated by long-distance chromosome gyrations, multistep activation through a unique 
doubly-paused Pol II which, in association with the monocyte lineage factor Spi1/PU.1 
(Spi1), maintains a low TBP and Pol II occupancy prior to activation. Activation and 
DNA binding of the transcription factors C/EBP and NF-B resulted in de novo 
recruitment of TBP and Pol II to IL1B in concert with a permissive state for elongation 
mediated by the recruitment of the positive elongation factor b (P-TEFb). This Spi1-
dependent mechanism for IL1B transcription, which is unique for a rapidly-
induced/poised IE gene, was more dependent upon P-TEFb than was the case for the 
TNF gene. Nucleosome occupancy and chromatin modification analyses of the IL1B and 
TNF promoters, revealed activation-specific changes in chromatin marks that are 
supportive for nucleosome clearance and formation of nucleosome free regions (NFR). 
Furthermore, ectopic expression of Spi1, along with a TLR surrogate (over-expressed 
TNF receptor associated factor 6, TRAF6), in a cell line incompetent for IL1B 
transcription, is observed to prime the cell’s endogenous genome for IL1B induction by 
appropriately phasing promoter nucleosomes and recruiting paused Pol II in a manner 
reminiscent of that observed in competent monocytes. Here I report a novel connection 
between the metabolic state of cells and HIF-1 in regulating murine Il1b gene 
expression. With regard to the lipopolysaccharide (LPS) unresponsive state known as 
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endotoxin tolerance, my data revealed that following transient induction, IL1B and TNF 
remained marked with paused Pol II complexes for up to 24 hours post-stimulation. Upon 
subsequent LPS exposure, tolerized TNF remained in an unresponsive paused state, while 
IL1B resumed transcription due to recruitment of positive elongation kinase P-TEFb. 
Emerging evidence suggests that inflammatory responses of LPS/TLR4 activated 
macrophages are interconnected with metabolic pathways, resulting in the shift of energy 
utilization by the cells. Here I report that inhibition of either phosphoinositide 3-kinase 
(PI3K) or glucose metabolism had a greater affect on the transcriptional response of Il1b 
than of Tnf. The differences between these two genes, especially for endotoxin tolerance, 
suggest that il1b may play a distinct role from tnf in chronic inflammation. 
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INTRODUCTION 
 
 
Innate Immune System, Toll-like Receptors and LPS Sensing 
The immune system is an integrative network of organs, cells and defensive 
molecules capable of mounting protective responses against invading microorganisms. 
The evolution of vertebrate immunity was driven by a continuous challenge from the 
external environment mediated by interactions with a surrounding microbial world. Such 
homeostasis between the host organism and pathogens provided a framework for the 
expansion of various defense mechanisms, which are inherently tuned to distinguish and 
eliminate the microbial pathogens (Iwasaki and Medzhitov, 2010). However not all 
microbes are harmful. Adaptation of the immune system also led to the development of a 
symbiotic homeostasis with the various types of microorganisms. Enterobacteria residing 
within selective segments of the vertebrate digestive tract are an example of a symbiotic 
relationship. A specialized branch of the immune system associated with fostering gut 
microbes has evolved to maintain their metabolic benefits to the host (Hooper et al., 
2012).  In addition to the recognition of foreign substances, immune-surveillance is also 
primed to detect various features associated with physiologically altered cancerous and/or 
virus-infected host cells.  
Innate immunity, as the first line of host defense, consists of a series of 
anatomical, physiological and phagocytic barriers. These mechanisms are present prior to 
the onset of infection in order to effectively initiate a set of rapid responses mediating the 
clearance of pathogens.  When activated, components of the innate immune system 
trigger the adaptive defense mechanisms consisting of the T cell and B cell mediated 
responses (Akira et al., 2001). The hallmarks of acquired immunity include the high 
2 
 
specificity against a diverse set of antigens, immunologic memory and the prevention 
from initiating detrimental autoimmune responses. The integration of the innate and 
adaptive branches during the immune response results in a precise recognition of the 
invading pathogen, its effective clearance, and a build up of long-term memory against it, 
enabling a protection during the subsequent exposures.   
The hallmark of the innate immune defense involves a set of protective 
mechanisms activated during tissue injury collectively known as the inflammatory 
response, which provides “non-specific” destruction of microbes and prevents the 
spreading of infection throughout a host organism. Initiation of this response requires a 
detection of microbial components by phagocytic cells such as neutrophils, monocytes 
and macrophages.  Upon the recognition of pro-inflammatory, metabolic or immune 
stimuli, monocytes, comprising 10% of leukocytes in blood (Auffray et al., 2009), 
migrate into various anatomical locations where they differentiate into various types of 
macrophages and dendritic cells. The specific microenvironments within the peripheral 
tissues induce specialization of the individual macrophages into various sub-populations. 
These include the interstitial and alveolar macrophages (lungs), Kupffer cells (liver), 
Langerhan cells (skin), pleural and peritoneal macrophages (serous cavities), microglial 
cells (brain), and osteoclasts (bone) (Auwerx, 1991; Gordon and Taylor, 2005). These 
scavenger phagocytes detect the conserved metabolites unique to the microbial world, 
known as the pathogen-associated molecular patterns (PAMPs), by means of distinct 
types of pattern recognition receptors (PRRs) situated on their membrane surface as well 
as within the intracellular compartments. These receptor sensors and their associated 
signaling pathways are evolutionarily conserved throughout the animal and plant 
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kingdoms (O'Neill, 2011). PAMPs (LPS, flagellin, bacterial and viral unmethylated CpG 
DNA, to name few) are constitutively expressed metabolic products that are central to 
microbial survival. Since they are highly conserved among the different classes of 
microbes, the innate immune system evolved various mechanisms to specifically target 
these molecular patterns (Medzhitov, 2001). The continuously scavenging PRRs are also 
responsive to a variety of common endogenous products that are abnormally released 
from damaged tissues and necrotic cells, commonly known as the “Damage or Danger” 
associated molecular patterns (DAMPs). For instance the heat shock proteins, uric acid, 
ATP, defensins, and HMGB1, are released from dying cells that are harmed during 
common tissue injury, or by the effects of catalytic enzymes and reactive nitric oxide 
species released non-specifically from the surrounded inflamed areas (Bianchi, 2007; 
Kono and Rock, 2008).  
Short-term effects of the inflammation controlling the protection and healing 
activities associated with tissue damage have beneficial effects. However the sites of 
infection or injury can also lead to the chronic (long-term) inflammatory responses that 
are the basis for the etiology of numerous diseases. Emerging evidence also suggests that 
inflammation can contribute to cancerous malignancies, due to a presence of various 
proliferative growth factors and stimulatory molecules that are vastly present in the 
inflamed tissues. In addition, the use of various receptors and adhesion molecules utilized 
by the spreading metastatic cells closely resemble the mechanisms associated with a 
tissue invasion of inflammatory cells (Coussens and Werb, 2002). 
The toll-like receptors (TLR) are a super-family of germ-line encoded PRRs, 
found in plants, invertebrates, and mammals, which are known to recognize the diverse 
4 
 
classes of bacterial, fungal and microbial components (Armant and Fenton, 2002). Initial 
studies of a Drosophila melanogaster plasma membrane protein, Toll, led to the 
identification of a highly conserved family of ten human and twelve murine TLRs 
(Takeda and Akira, 2005). Each member of the TLR family can recognize distinct classes 
of molecules that are unique to microbes. In addition, these membrane receptors can form 
dimers and expand their scavenger potential. For instance the heterodimeric combinations 
TLR2/TLR1 and TLR2/TLR6 recognize extracellular lipopeptides and lipoproteins that 
are part of the bacterial cell walls. On the other hand TLR members 3, 7, 8, and 9 are 
strategically positioned within the intracellular compartments recognizing single and 
double stranded microbial nucleic acids (Kang and Lee, 2011). Lipopolysaccharide (LPS) 
is a unique component of gram-negative bacterial cell walls recognized by the family 
member TLR4, which is present at the cell surface of monocytes and various tissue 
macrophages. Binding of this endotoxin to the receptor transduces information from the 
cell surface to the cytoplasm where it stimulates a cascade of events involving various 
cytoplasmic factors, many of which are pre-made in the resting cells. During the final 
steps of signaling, protein kinase cascades and various enzymes converge and modify 
(for instance by phosphorylation, or ubiquitylation) the inactive transcription factors and 
their regulators residing within the cytoplasm. The altered/activated transcription factors 
can then translocate to the nucleus where they act as transcription activators and/or 
repressors affecting the induction of specific genes.  
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NF-B and C/EBPβ 
A classical example of sub-cellular sequestration is represented by the nuclear 
factor (NF)-kappaB (NF-B) family of transcription factors, which are complexed with 
IB inhibitor proteins. In resting monocytes, the latent NF-B residing in the cytoplasm 
is bound by a member of the inhibitory IB family of proteins. TLR4 stimulation 
activates IKK kinase (via ubiquitin ligase TRAF6), which phosphorylates IB. This 
modification causes IKK degradation and the subsequent release of the active form of 
NF-B, which translocates to the nucleus (Chen and Greene, 2004). Figure 1 illustrates 
this TRAF6 mediated activation pathway. The NF-B family of proteins consists of the 
“NF-B” proteins (NF-B1 and NF-B2) and the three “Rel” subfamily proteins (RelA 
(p65), RelB and c-Rel). Initially translated as long precursors, NF-B1 (p105) and NF-
B2 (p100) are cleaved into functional transcription factors p50 and p52, respectively 
(Radisky and Bissell, 2007). These two precursor members possess an extended C-
terminal IB-like domain, which facilitates their auto-inhibition and cytoplasmic 
retention (Kawai and Akira, 2007). RelA (p65), RelB and c-Rel do not require proteolytic 
processing for activation. In contrast to NF-B1 and NF-B2, the C-terminal portion of 
the Rel members contains a transactivation domain (TAD), which supports gene 
activation. A highly conserved Rel-homology domain (RHD) is a shared feature among 
all family members. This domain mediates DNA binding as well as dimerization among 
the family members (Gilmore, 2006). 
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Figure1. The TLR4 meditated activation of NF-B and C/EBPβ.  
LPS binding causes the transmembrane pattern recognition receptor TLR4 to convey the activation signal 
into the cytoplasm through the signaling molecule TRAF6. Represented are two distinct signaling pathways 
downstream of TRAF6, which involve a cascade of adaptor proteins that activate transcription factors 
NF-B and C/EBPβ. Shown are the target sites for inhibitors MG132 (NF-B) and U0126 (C/EBPβ) used 
in this study. While MG132 blocks IKK induced proteosome degradation of the inhibitory IB protein, 
U0126 strongly blocks the activation of ERK/MAPK phosphorylation pathway, and to a lesser degree the 
hyper-activation of NF-B p65. 
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The most prominent form of activated NF-B during TLR4 mediated signaling is 
a heterodimeric complex p65/p50 (Kawai and Akira, 2007). Upon translocation to the 
nucleus, the activated dimer binds to DNA sequences located within the regulatory 
regions of numerous pro-inflammatory genes and influences their transcription (Radisky 
and Bissell, 2007). An additional regulatory layer associated with NF-B mediated 
transcriptional activation resides within its TAD. The NF-B p65 TAD was shown to 
associate with the general transcription factor TATA-binding protein (TBP), transcription 
factor IIB (TFIIB) as well as the coactivators histone acetyl transferase (HAT) p300 and 
cyclic-AMP-response element (CREB) binding protein (CBP) (Chen and Greene, 2004). 
Deregulation of NF-B signaling is often associated with the etiology of various forms of 
inflammatory diseases and malignancies due to its pleiotropic effects influencing several 
aspects of cell physiology, such as apoptosis and proliferation (Naugler and Karin, 2008).  
The CCAAT/enhancer-binding protein (C/EBP) family of basic leucine zipper 
(bZIP) transcription factors plays an important role in regulating gene expression during 
immune responses, proliferation, and cell differentiation. The six members of C/EBP 
family include C/EBPα, C/EBPβ, C/EBPγ, C/EBPδ, C/EBPε and C/EBPδ. While 
C/EBPα, C/EBPβ and C/EBPγ are virtually universally expressed, the others are either 
inducible (C/EBPδ), or their expression is confined to selected cell types of the 
hematopoietic system (C/EBPε) (Johnson, 2005). LPS signaling in monoctyes initiates 
several mitogen activated protein kinase (MAPK) pathways, which ultimately converge 
to activate C/EBPβ. Both, the DNA binding and homotypic dimerization domains of the 
C/EBP members are confined to their C-terminal bZIP domain. This highly conserved 
basic DNA binding module also functions as the nuclear localization signal. The amino 
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terminal portion of C/EBPβ contains the TAD, as well as a signal-responsive regulatory 
domain (Johnson, 2005; Tsukada et al., 2011). Figure 1 depicts the activation of C/EBPβ 
during the TLR4 signaling pathway, initiated by the small GTPase Ras. This mediator 
induces c-Raf and stimulates the MEK1/ERK1 transduction cascade to phosphorylate 
C/EBPβ, which undergoes a conformational change (Guha and Mackman, 2001). The 
inducible activation of C/EBPβ plays an important role in triggering the expression of 
various cytokines during the inflammatory response and genes controlling the acute-
phase response and differentiation of hematopoietic cells (Tsukada et al., 2011). In 
addition to interacting with transcription factors such as c-Myb (Tsukada et al., 2011), 
C/EBPβ can synergistically interact with the chromatin remodeling SWI/SNF complexes 
(Kowenz-Leutz and Leutz, 1999), as well as transcriptional coactivators such as HATs, 
CBP and p300. These protein associations induce gene expression by promoting 
transcription permissive histone modifications (acetylation), nucleosome remodeling and 
the recruitment of general transcription factors to gene promoters (Kovacs et al., 2003).  
 
Monocyte/Macrophage Gene Networks, Nucleosome Positioning and Pol II Pausing 
LPS-stimulated monocytes activate distinctive sets of genes responsible for the 
initiation of appropriate immune-physiological responses that are characteristic for these 
cells. These gene networks are activated sequentially in a time dependent fashion, 
producing waves of immediate-early, early, and late gene transcription. For instance, the 
pathogen activated dendritic cells (DCs) rapidly repress genes associated with 
phagocytosis and pathogen recognition. At the same time these cells up-regulate the 
transcription of genes encoding immune products responsible for the recruitment of 
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monocytes, DCs, and macrophages to infected body areas (Huang et al., 2001). 
The first wave of the inducible gene network up-regulated by pathogen-stimulated 
mononuclear cells encodes a variety of effector proteins with pleitropic biological 
activities. This class of primary immediate early (IE) genes codes for potent pro-
inflammatory cytokines and chemokines that play a prominent role during the 
manifestation of the inflammatory response. The transcription of these genes is highly 
regulated, as their products are associated with potent immune-stimulatory and cytotoxic 
properties. Locally they can induce vasodilation by altering endothelial cells and 
stimulate recruitment of neutrophils and macrophages to the site of infection. 
Additionally, they mediate various systemic responses such as fever (hypothalamus) and 
the acute phase response (liver) (Smale, 2010). If not properly contained, the prolonged 
expression of these toxic molecules has harmful and destructive effects associated with 
chronic inflammation. The stimulus selective and inducible expression of the IE genes is 
often restricted to a specific cell type, and their expression does not require de novo 
protein synthesis (Herschman, 1991). Efficient activation of the IE responders requires a 
collaborative endeavor of transcription factors, coactivators, and chromatin modifiers, 
targeted to the regulatory sequences residing within gene promoters and enhancers. 
Various combinations of these factors are recruited to the regulatory regions of IE genes 
to establish favorable chromatin architecture and mediate recruitment of the transcription 
machinery. Often being separated by thousands of base pairs, the transcription factors 
mediate physical associations between distant promoters and enhancers to serve as an 
additional regulatory step controlling gene expression.  In resting cells, IE genes are 
maintained in a repressed/poised state ready for a rapid induction in response to stimulus.  
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Eukaryotes package their DNA into a higher order structure known as the 
chromatin fiber. The basic units of chromatin are nucleosomes, which are comprised of 2 
copies of 4 core histone proteins H2A, H2B, H3, and H4. The central H3/H4 tetramer is 
surrounded by the H2A/H2B dimers (Henikoff, 2008). The 147 bp of DNA wrapped 1.65 
turns around each of these octameric structures represent the fundamental unit of the 
chromatin fiber (Radman-Livaja and Rando, 2010). An average distance between the 
midpoints of two nuclesosmes compacting the human genome is approximately 185 bp. 
Nucleosome positioning throughout the genome plays a major role in controlling the 
accessibility of DNA regulatory regions and influencing gene expression. Nucleosome 
positioning often corresponds to the transcriptional activity of a particular gene. For 
instance, the promoters of active genes are usually associated with a nucleosome free 
region (NFR), which facilitates the formation of pre-initiation complex formation (PIC) 
and RNA Polymerase II (Pol II) entry. The first, and usually most prominent, phased 
nucleosome (non-randomly positioned nucleosome along DNA) downstream of the TSS 
is referred to as +1. Contrary to yeast, in humans the nucleosome positioned within the 
NFR is defined as -1 and the first most prominent nucleosome upstream of the TSS is 
designated as -2. An additional aspect of gene packaging lies within the nature of 
covalent modifications associated with the N-terminal nucleosome histone tails that are 
subjected to the binding of various histone modifiers and transcriptional activators and 
repressors (Jiang and Pugh, 2009). Figure 2 illustrates the nucleosome positions, Pol II 
occupancy, and the spatial distribution of several chromatin marks used in literature and 
this study as common indicators of transcriptional competency.   
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Figure 2. Illustration of the paused Pol II dynamics and chromatin landscape along a typical gene.  
Shown here are the various transcriptional permissive (+) and repressive (-) chromatin marks as well as 
their reported distribution throughout a typical gene locus (Henikoff and Shilatifard, 2011; Owen-Hughes 
and Gkikopoulos, 2012). Transcriptionally permissive modifications include H3K9ac, H3K4me3, 
H3K36me3, H3K4me1, and H3K27ac. H3K9ac is present at the promoter, H3K4me3 is most abundant in 
the vicinity of the +1 nucleosome, H3K36me3 increases towards the 3’ end of the structural gene, and 
H3K27ac is distributed upstream and throughout the gene locus (Henikoff and Shilatifard, 2011; Owen-
Hughes and Gkikopoulos, 2012). H3K4me1 marks enhancers of LPS inducible genes within the setting of a 
macrophage genome (Ghisletti et al., 2010; Heinz et al., 2010). Transcriptionally inactive genes are 
enriched for modifications such as H3K9me1 and H3K27me3. Typically phased nucleosomes are labeled 
according to their position relative to the transcription start site (TSS). Illustrated is also the Pol II 
progression throughout the locus. The paused Pol II complex is represented as a peak, located 50bp beyond 
TSS. Paused Pol II is associated with the C-terminal domain phosphorylation at serine 5 and the presence 
of negative elongation factor (NELF). The interplay between NELF and positive elongation factor b (P-
TEFb) regulates the Pol II transition into the elongation state.  
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Recent reports from Drosophila and human genome studies revealed a new 
regulatory step within the transcriptional cycle of Pol II. These observations changed the 
way we think about transcriptional control of primary response genes. Pol II is pre-loaded 
at the 5’ regions of many genes that are inactive or minimally expressed (Gilchrist et al., 
2008; Guenther et al., 2007; Kininis et al., 2009; Muse et al., 2007; Rahl et al., 2010; 
Zeitlinger et al., 2007). In addition, TBP appears to be constitutively present on these 
genes (Donner, 2010). As shown by in vitro studies, these complexes are poised for rapid 
transcription, and will resume elongation upon the addition of nucleotides (Fish and 
Kane, 2002; Greive and von Hippel, 2005). Activation of the paused genes by an 
exposure of cells to developmental and environmental stimuli is dependent on the release 
of Pol II from its paused state (Wu and Snyder, 2008). The interplay of several elongation 
factors and chromatin modifiers is responsible for maintaining and liberating the paused 
Pol II. One of the proteins that induces Pol II stalling is the negative elongation factor 
(NELF), composed of four subunits, NELF-A, NELF-B, NELF-C/D, and NELF-E, which 
was proposed to interact with the nascent RNA emerging from Pol II, using its RNA 
recognition motif (RRM) (Gilchrist et al., 2008; Wu et al., 2003; Yamaguchi et al., 2002). 
Positive transcription-elongation factor-b (P-TEFb) has been shown to rescue the paused 
Pol II by simultaneously phosphorylating NELF as well as the Pol II C-terminal domain 
at serine 2 (S2P CTD), causing its transition into the state of elongation (Bres et al., 2008; 
Ni et al., 2008; Price, 2000). The differential modifications of Pol II CTD, as well as its 
interactions with the components of the splicing machinery, play a crucial role during the 
regulation of transcriptional dynamics. The mammalian CTD is a part of the largest Pol II 
subunit (RPB1) and contains 52 tandem repeats of a heptapeptide with the consensus 
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sequence Tyr-Ser-Pro-Thr-Ser-Pro-Ser (Buratowski, 2009). It has been postulated that 
the differential phosphorylation states of the CTD correspond to either a paused or an 
actively elongating Pol II. The phospho-serine 5 modified CTD (S5P CTD) is located 
primarily at the upstream regions of the genes as part of the engaged but stalled Pol II 
complex. Cyclin-dependent kinase 7 (CDK7), a subunit of the general transcription factor 
TFIIH, has been shown to mediate this S5P phosphorylation event, since the newly 
recruited Pol II is in a hypo-phosphorylated state (Brookes and Pombo, 2009).  This 
modification aids in the process of the methylguanosine cap addition to the 5’ end of the 
nascent mRNAs. ChIP experiments have shown that serine 2 phosphorylation by P-TEFb 
(which contains a CDK9 subunit) increases towards the 3’ end of the actively transcribed 
genes. The serine 7 phosphorylation (S7P) serves as an additional site for Pol II CTD 
phosphorylation at a subset of genes encoding small nuclear (sn) RNAs in mammalian 
genomes (Egloff, 2012). This S7P modification is recognized by the RNA Pol II-
associated protein 2 (RPAP2), which recruits the Integrator complex responsible for the 
RNA 3’ end processing (Egloff et al., 2012).  The spatial alteration of the CTD 
phosphorylation pattern corresponds to the recruitment of various factors responsible for 
proper pre-mRNA co-transcriptional processing including splicing and addition of the 
poly-A tail (Buratowski, 2003; Egloff and Murphy, 2008). In addition, the sequentially 
phospho-modified CTD serves as a landing pad for the recruitment of chromatin 
remodeling and modifying factors including the histone methyltransferases Set1 and 
Set2, as well as the histone acetyltransferases CBP/p300 and PCAF (Brookes and Pombo, 
2009; Munoz et al., 2010; Weake and Workman, 2010). In fact, a specific set of 
chromatin marks, which are differentially distributed throughout the gene coding and 
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regulatory regions, have also been associated with Pol II transcription dynamics.  For 
instance, tri-methylation of lysine 4 at histone 3 (H3K4me3) and the acetylation of lysine 
9 at histone 3 (H3K9ac) are present at the promoter proximal regions of either actively 
transcribed or paused genes. In contrast, the tri-methylated lysine 36 of histone 3 
(H3K36me3) downstream of the gene promoters is associated with actively elongating 
Pol II complexes (Brookes and Pombo, 2009; Wu and Snyder, 2008).  
The phenomenon of Pol II pausing is thought to contribute to gene regulation in a 
variety of ways. Some reports indicate that the paused Pol II complexes provide a means 
for a rapid transcriptional response, as well as the coordinate induction of multiple genes 
(Fuda et al., 2009). Evidence suggests that Pol II pausing ensures the proper assembly of 
capping factors at the 5’ end of genes, as well as the accurate formation of a Pol II 
elongation complex. Additional reports indicate that Pol II also pauses at the 3’ end of 
genes, where it associates with protein machineries that direct the final steps of mRNA 
processing, including cleavage and polyadenylation (Glover-Cutter et al., 2008). Lastly, 
studies in Drosophila showed that the stalled Pol II serves as a physical barrier by 
preventing promoter-proximal nucleosome assembly (Gilchrist et al., 2008). This 
mechanism contributes to the accessibility of the core promoter for subsequent 
recruitment of Pol II and proper gene activation (Gilchrist et al., 2008).  Pol II pausing is 
also associated with the negative regulation of gene expression. As recently reported, the 
NELF-induced paused Pol II complex at the JunB promoter is present prior to induction 
and persists during the transcription of the gene.  According to the report, the gene is not 
activated to the full extent, because of the attenuating effects of paused Pol II (Aida et al., 
2006). Additional studies investigating Pol II pausing will be required in order to better 
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resolve the role played by this regulatory step that influences the transcription of 
eukaryotic genes.  
 
A signal (LPS) inducible enhancer and a cell type specific promoter constitute the 
main regulatory regions of the human IL1B gene. 
Interleukin-1 (IL-1) is a potent mediator of inflammatory responses with 
diverse biological activities affecting the endocrine, nervous, and immune systems. IL-1 
has been shown to cause fever, activate acute-phase responses, modulate lymphocyte 
function, as well as induce both destructive and reparative changes in mesenchymal 
tissues (cartilage, bode, muscle) (Dinarello, 1986; Dinarello, 1994). The gene encoding 
IL-1 is located on human chromosome 2 within the homologous IL-1 family gene 
cluster, which contains 8 additional IL-1-like genes whose products have also been 
associated with diverse pro- and anti-inflammatory activities. The primary sources of this 
molecule in humans and mouse are activated monocytes/macrophages as well as related 
cells of the myeloid lineage. The transcriptional profile of IL1B in stimulated monocytes 
is reflected by rapid induction followed by a decreased sustained expression that lasts for 
several hours (Fenton et al., 1987). The past work in our and other groups has revealed 
numerous regulatory sequences upstream of the IL1B coding region that bind an array of 
transcription factors, including Spi1/PU.1 (Spi1), C/EBP, NF-B p65, IRF4/8, and 
CREB, some of which are restricted to the monocytic-cell lineage, such as Spi1, and 
IRF4/8. Transcription factor interactions and binding to different positions along the IL1B 
regulatory regions likely account for the stringent regulation of this IE gene. In the past, 
the study of IL1B regulatory regions focused primarily on defining the specific DNA 
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sequences and their capabilities for binding various transcriptional activators. The past 
collection of studies resulted in the comprehensive dissection of the complex regulatory 
elements within the IL1B locus. Figure 3 depicts the schematic representation of IL1B 
regulatory regions as well as the associated binding of transcription factors controlling 
IL1B transcription. Transient transfection studies using selected fragments of the IL1B 
trans-gene into murine RAW 264.7 (RAW) monocytes, revealed important regulatory 
sequences 3kb upstream of the TSS between -3134 and -2729 (Shirakawa et al., 1993). 
This stimulus-specific enhancer, termed the upstream induction sequence (UIS), is 
divided into 9 distinct regions (A through I) some of which contain collections of binding 
sites for an array of constitutively bound, as well as inducible, transcription factors. The 
C/EBP, a critical myeloid gene regulator (Pham et al., 2007), binds to the enhancer E 
and I regions following LPS stimulation. Mutation of these binding sites reduces the 
activity of IL1B promoter driven CAT plasmids transfected into monocyte cell lines, 
suggesting its functional role in the gene activation (Shirakawa et al., 1993; Tsukada et 
al., 1994b). 
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Figure 3. Depiction of the IL1B gene regulatory region. 
Shown are the various regulatory regions that are known to affect IL1B induction. Magnified on the bottom 
left are the enhancer regions and top right the promoter transcription factor binding sites. LPS induced 
binding of the effector proteins is highlighted with red boxes and arrows.  Illustrated is also the enhancer 
specific protein complex binding to the LILRE, as well as the looping mediated by the association of 
constitutive Spi1 (promoter) and LPS induced C/EBP (enhancer). Figure was provided by the courtesy of 
P.E. Auron. 
 
In addition, these studies revealed an important role of the interferon stimulation 
response element (NF-1) binding site within the enhancer F region during IL1B 
regulation. Chromatin immuno-precipitation (ChIP) studies showed cooperative 
association of non-tyrosine phosphorylated (NTP)-Stat1, IRF-8 and Spi1 bound to an 
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LPS/IL-1 Responsive Element (LILRE), located between the positions -2880 and -2849 
in unstimulated monocytes. Upon LPS treatment, the trans-activation domain of IRF8 
likely becomes phosphorylated at the tyrosine residue 727, possibly acting as a switch 
necessary for the rapid activation (up to 80%) of IL1B transcription (Unlu et al., 2007). 
Continuing with this mechanism, a recent study argued that LPS activates a casein 
kinase-2 (CK2)-dependent phosphorylation of the pre-associated Spi1 within the 
complex. This phosphorylation event of Spi1 at the serine 148 triggers the replacement of 
IRF-8 by its relative IRF4, which acts to enhance the recruitment of Pol II complex to the 
IL1B promoter (Zhang et al., 2008). Another site within the UIS that is necessary for 
proper IL1B gene activation is located within the enhancer I-region (-2768 to -2760), 
which contains the composite sequences recruiting competing heterodimeric complexes 
consisting of C/EBPβ and CREB and a CREB-like factor, possibly ATF4 (Figure 3) 
(Auron and Webb, 1994; Chandra et al., 1995; Tsukada et al., 1994). All of these 
activators and their modifications are needed for proper IL1B induction, in order to 
overcome the unknown nature of the potent suppressive effect of region H in the 
enhancer, which acts as a silencer for LPS induction (Tsukada et al., 1994b). Another 
feature likely enabling the observed rapid induction of IL1B is associated with the 
accessible/nucleosome-free promoter architecture, containing constitutively bound 
transcription factors and activators (Liang et al., 2006). One such protein, central to IL1B 
expression, is the previously mentioned Spi1, an ETS domain helix-turn-helix (HTH) 
DNA binding factor exclusively expressed in the monocytes/myelocytes, B cells, mast 
cells, and erythropoietic stem cells (Nishiyama et al., 2004; Pahl et al., 1993). It has been 
postulated that this lineage-determining factor facilitates the formation of a NFR, 
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exposing binding sites for the LPS-responsive transcription factors in activated 
monocytes (Natoli, 2012). Spi1 is a major factor involved in the genome-wide 
maintenance of the macrophage lineage (Lawrence and Natoli, 2011). In particular, 
recent genome-wide studies revealed a constitutive association of Spi1, often with other 
signal inducible factors such as NF-B and C/EBPβ, at the LPS responsive enhancers in 
murine macrophages (Ghisletti et al., 2010; Heinz et al., 2010). It is speculated that the 
cell-type-restricted expression of IL1B is dependent on Spi1, which constitutively binds 
to the promoter at two distinct sites located between -50 to -39 and -115 to -97, relative to 
the TSS (Figure 3) (Kominato et al., 1995). In addition to its role as a pioneer factor, 
which is capable of binding nucleosome-wrapped DNA and facilitating chromatin 
accessibility (Marecki et al., 2004), Spi1 also recruits various activators such as the 
HMGB1 (Mouri et al., 2008), JunB (Grondin et al., 2007) and the general transcription 
factor TBP, involved in the pre-initiation complex (PIC) formation, responsible for Pol II 
recruitment to the promoter (Hagemeier et al., 1993). Our group proposed that C/EBP 
bound to the enhancer physically interacts with Spi1 located at the IL1B core promoter 
and cooperatively initiates IL1B gene induction. This protein-protein tethering would 
bring the IL1B enhancer and promoter into a close proximity resulting in a loop formation 
that enhances gene activation (Listman et al., 2005; Yang et al., 2000). In addition to the 
enhancer-binding sites, the IL1B promoter also contains two C/EBP binding sites 
positioned at -91 and -41 bp upstream of the TSS (Listman et al., 2005). Studies in mouse 
monocytes indicate that promoter bound (position -41) C/EBP undergoes p38 MAPK-
dependent phosphorylation that is required for IL1B induction (Baldassare et al., 1999). 
Finally, IL1B transcription requires the recruitment of NF-B p50-p65 hetero-dimer to a 
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putative binding site located 297 bp upstream of the TSS (Figure 3). Point mutations 
within this sequence significantly reduced IL1B activity (Hiscott et al., 1993). The proper 
activation of this inducible gene requires a series of combinatorial associations (often in 
protein complexes) and posttranslational modifications of these factors in a time-
dependent fashion that are ultimately responsible for the recruitment of Pol II to the IL1B 
promoter.  
 
IL-1 gene family members in human monocytes. 
 The human IL-1 family consists of 11 genes whose identity have been only 
recently identified and their biological relevance during the inflammatory responses is 
presently being investigated. The members include IL-1 (IL-1F1), IL-1 (IL-1F2), IL-1 
receptor antagonist IL-1Ra (IL-1F3), IL-18 (IL-1F4), IL-36ra (IL-1F5), IL-36 (IL-1F6), 
IL-37 (IL-1F7), IL-36 (IL-1F8), IL-36 (IL-1F9), IL-38 (IL-1F10), and the most 
recently added member IL-33 (IL-1F11). As Figure 4 illustrates, all of the members are 
mapped to a cluster on the long arm of chromosome 2, except IL-18 and IL-33 (not 
included in the Figure), which reside on chromosomes 11 and 9, respectively (Liew et al., 
2010). Emerging evidence suggests that IL-1, IL-1, IL-18, IL-36, IL-36, IL-36, 
and IL-33 have pro-inflammatory, while IL-1Ra, IL-36ra, and IL-37 have anti-
inflammatory, functions. The role of IL-1F10 during the mediation of immune responses 
is not well understood (Dinarello; Dunn et al., 2001). 
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Figure 4. IL-1 family gene cluster on the long arm of chromosome 2.  
Shown is a magnified section of the chromosome 2, which contains a gene cluster of 9 IL-1 family 
members. The arrows within the genes annotate their transcriptional direction. Certain genes show more 
then one predicted coding sequences of varying lengths. This figure was generated using the UCSC 
genome browser website. 
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Endotoxin Tolerance 
Endotoxin tolerance, also known as desensitization, is defined as a decreased 
responsiveness of the host’s (cells and organisms) to either repeated or prolonged LPS 
stimuli, after an initiation of the primary immune response (Fan and Cook, 2004). This 
state of immune-paralysis has been associated with a protective function, in preventing 
the excessive and uncontrolled onset of potentially harmful inflammatory responses to 
the host organism (Arbibe and Sansonetti, 2007). The first evidence suggesting endotoxin 
tolerance came from the 1947 reports by Beeson. His studies revealed decreased fever 
responses in rabbits repeatedly treated with bacterial pyrogens (Beeson, 1947a, b). 
Although some aspects of the endotoxin tolerance phenomenon have been elucidated, the 
mechanisms at the level of transcriptional regulation are still largely unknown. In the 
search for new answers, various laboratories often used a variable experimental set up in 
cell culturing and LPS treatment that resulted in some inconsistent results throughout the 
literature. A recent study using murine bone marrow-derived macrophages categorized 
the LPS responsive genes into two classes, tolerant and non-tolerant.  The report argues 
that the protein products of the tolerant genes are associated with potent pro-
inflammatory functions and therefore their expression is rapid and transient. They are 
refractory to an additional stimulus in order to prevent their harmful effects and potential 
tissue damage. On the other hand, the genes in the non-tolerant category encode various 
anti-microbial products whose expression remains inducible even after the repeated 
stimuli. These molecules are not associated with the harmful effects to the host. Instead, 
their re-activation is beneficial to the host by providing long-term protection form 
invading pathogens. The hypo-responsiveness of the tolerant genes was attributed to the 
23 
 
loss of histone modifications associated with gene activation (Foster et al., 2007). Both, 
TNF and IL1B were included in the list of genes that were unable to respond to the 
secondary LPS challenge. The issue of chromatin dynamics during endotoxin tolerance 
was explored by Gazzar et. al, indicating that increased repressive methylation at 
H3K9me1, induced binding of heterochromatin-binding protein 1 (HP1) to TNF 
causing its transcriptional repression (El Gazzar et al., 2007). Additionally, a series of 
studies showed that the tolerant phenotype results form an increase in the nuclear 
concentration of NF-B p50–p50 homodimer, which lacks a proper TAD, causing 
transcriptional deregulation of specific genes including TNF and IL1B (Kastenbauer and 
Ziegler-Heitbrock, 1999; Ziegler-Heitbrock et al., 1994). Two reports using human cell 
lines (LaRue and McCall, 1994) and a mouse model (Zuckerman et al., 1991) revealed 
two contradictory tolerant and non-tolerant properties, respectively, for the il1b gene, 
adding more dilemma to the endotoxin tolerance subject. Previous studies in our 
laboratory also showed a partial incomplete IL1B tolerance of LPS (Fenton et al., 1987) 
and a novel complete tolerant property for IL1B by using phorbol ester (PMA) as the 
secondary challenge (Fenton et al., 1987).  Lastly, a recent study using non-monocytic 
cells showed that endotoxin tolerance manifests itself in a cell type specific manner 
(Wang et al., 2011). Collectively these reports suggest that the many aspects of endotoxin 
tolerance associated with transcriptional repression are still not well understood. 
Although the tolerant nature of TNF has been consistently reported, studies of IL1B 
tolerance are not yet conclusive. Since the effects of endotoxin tolerance are evident in 
various diseased states, including sepsis, non-infections systemic inflammatory 
responses, trauma, and hemorrhagic shock, the understating of the underlying 
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mechanisms associated with this phenomenon is significant for their treatment (Cavaillon 
et al., 2003).  
 
The Role of HIF-1 in innate immunity and cancer 
Hypoxia induced factor (HIF-1) plays a major role as a regulator of oxygen homeostasis 
in cells. During the state of normal oxygen levels (normoxia), HIF-1, a helix-loop-helix 
DNA binding factor, rapidly undergoes post-translational modification by the action of 
the enzyme prolyl hydroxylase (PHD), which causes the ubiquitin-mediated degradation 
of HIF-1. The PHD activity is inhibited under conditions of oxygen deprivation 
(hypoxia), which induces HIF-1 stabilization and subsequent translocation to the 
nucleus, where it binds a DNA recognition motif known as the hypoxia-response element 
(HRE) and associates with co-activators such as p300/CBP, which activate target genes 
(Semenza, 2003) (Figure 5). Since hypoxia is a well-known feature of inflamed and 
cancerous tissues, the understanding of the homeostatic imbalance of HIF-1 activity has 
significant clinical implications.  
Otto Warbug reported the first connection between malignant cells and metabolic 
activity in 1927 (Warburg et al., 1927). Today, it is well established that tumor cells 
undergo a metabolic shift resulting in the upregulation of the anaerobic glycolysis as a 
major source for their energy production. The alteration of mitochondrial physiology is 
due to mutations in the genes encoding succinate dehydrogenase (SDH) and fumarate 
hydratase (FH) enzymes associated with the TCA (Krebs) cycle, which links glucose 
utilization with oxidative phosphorylation (Gottlieb and Tomlinson, 2005). Often 
associated with the state of pseudo-hypoxia, the buildup of succinate and fumarate acts as 
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a direct inhibitor of PHD, causing activation of HIF-1. HIF-1, in turn, causes the up-
regulation of genes involved in the anaerobic glycolysis, promoting neurovascularization 
and deregulation of cell apoptosis (Gottlieb and Tomlinson, 2005), contributing to the 
tumorigenesis. The metabolic changes associated with the upregulation of anaerobic 
glycolysis are also apparent in mononuclear cells residing within tumors and inflamed 
tissues (Tannahill and O'Neill, 2011). Several physiological processes controlling 
macrophage activity within inflamed and ischemic tissues are closely associated with 
HIF-1 mediated alterations in the transcription of a wide array of target genes. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Glucose metabolism and regulation of HIF-1.  
Shown is a glycolysis pathway and the effects of various substrates (mediating a pseudo-hypoxia) whose 
build-up causes inhibition of prolyl hydroxylase (PHD) and the up-regulation of HIF-1. Inhibitory 
pathways are marked with red colors. The effects associated with a drop in oxygen levels (hypoxia) are also 
depicted in the Figure.  
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The hypoxic microenvironment of inflamed tissues has been shown to trigger 
HIF-1 and alter the expression of proteins associated with macrophage survival, 
expression of cytokines/chemokines, and tissue angiogenesis (Murdoch et al., 2005). In 
addition to relieving the inhibitory effects of PHD, the TLR4 mediated activation of NF-
B was shown to augment the transcription of Hif1 and further amplify its regulatory 
potential (Nizet and Johnson, 2009).  
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HYPOTHESIS AND SPECIFIC AIMS 
IL1B and TNF are immediate early genes induced in response to TLR4 activation 
of monocytes. Upon monocyte stimulation, TNF undergoes rapid induction and complete 
transcriptional shut down within a few hours. IL1B is expressed with similar initial 
kinetics, but in contrast to TNF its expression is not completely inhibited and remains 
sustained for many hours post-stimulation. In addition, TNF is refractory to subsequent 
LPS stimulation. In contrast, IL1B is less sensitive to endotoxin tolerance and can be re-
activated when exposed to a secondary LPS challenge. One primary transcription factor 
NF-B has been reported to regulate the expression of these IE genes (Collart et al., 
1990; Hiscott et al., 1993). Since the expression profiles of IL1B and TNF are quite 
distinct, I hypothesize that additional regulatory mechanisms control the expression of 
IL1B. A series of kinetic ChIP experiments analyzing various transcription factors and 
nucleosome positioning and modification was performed in order to clarify the 
mechanisms responsible for the decreased, but sustained, transcriptional activity of IL1B, 
as well as its ability to escape endotoxin tolerance. In order to precisely define the 
importance of selected transcription factors, I performed transient transfection 
experiments using HEK 293 cells, as a “surrogate-monocyte” cell system. By adding 
combinations of signaling activators and transcription factors, an LPS stimulated 
monocyte environment can be mimicked within these cells with concomitant induction of 
developmentally quiescent IL1B. On the basis of in vitro studies, functional cooperation 
between enhancer bound C/EBP and promoter bound Spi1 via DNA looping has 
previously been proposed by our laboratory as a mechanism for IL1B induction (Listman 
et al., 2005; Yang et al., 2000). To validate the possible LPS induced chromatin looping 
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as a regulatory step for IL1B gene induction, chromatin conformation capture analysis 
was performed.  Lastly, I investigated the expression of IL-1 family members at the 
primary IL1 locus on chromosome 2 and two of its distant members on chromosomes 9 
and 11 in resting and activated human monocytes. According to my preliminary data, I 
hypothesize that this gene family will be coordinately expressed following LPS 
stimulation. The synchronous expression of the IL-1 gene family members suggests that 
they may be transcribed as a single structural-functional entity known as transcription 
factory. Since many transcriptional mechanisms are conserved among higher eukaryotes, 
the new information obtained from this research will be applicable to other rapidly 
induced genes. Because the regulation of gene expression is central to cell growth, 
differentiation, and physiological responses to environmental stress, it is important to 
understand the mechanisms underlying these processes. Especially important is the 
activation of pro-inflammatory genes such as IL1B, whose over-expressed bioactive 
products can be destructive to tissues. Given that extensive release of these 
homeostatic/immune-mediators is associated with numerous autoimmune diseases, an 
understanding of their transcriptional control can provide a means for developing new 
inhibitory therapeutics. Accordingly, the following specific aims were proposed in order 
to better understand the transcriptional regulation of IL1B:  
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Aim 1.  Execution of positional-temporal ChIP studies of IL1B vs. TNF induction and 
transcriptional shut down.    
 
Aim 2.  Resolving the molecular nature of gene specific desensitization/immune-
tolerance of IL1B and TNF genes.  
 
Aim 3.  Determining the role of Spi1 in induction of the IL1B gene and to characterize 
the relative importance of C/EBPβ and p65 during IL1B induction in monocytes and in 
HEK 293 cells supplemented by ectopic expression of monocyte-specific factor. 
 
Aim 4. Investigation of the LPS inducible mRNA expression of IL-1 gene family 
members in human monocytes.  
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MATERIALS AND METHODS 
 
Cell Culture  
THP-1 cells were cultured in RPMI media (10-040-CV, Cellgro) supplemented with 10% 
heat-inactivated fetal bovine serum (FBS), 1% Penicillin/Streptomycin solution (30-002-
CI, Cellgro) and 500 µl of 2ME (21985-023, Invitrogen). HEK 293 cells, MG 63 cells, 
grown in EMEM (10-010-CV, Cellgro) and HuT 102 cells grown in RPMI, containing 
10% heat-inactivated FBS and 1% Penicillin/Streptomycin Solution, were obtained from 
American Type Culture Collection. RAW 264.3 were cultured in DMEM (10-013-CV, 
Cellgro) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1% 
Penicillin/Streptomycin Solution. Adult human elutriated monocytes were purchased 
from Advanced Biotechnologies (07-210-001). Monocytes were cultured in DMEM with 
20% FBS (SH3007003N, Fisher), 1% Penicillin/Streptomycin, and 50 µg/ml Gentamicin 
(1676045, MP Biomedicals) for 7 days until macrophage monolayer was established. On 
day 7 and 8, 90% of the old media was replaced with 10 ml of fresh media to remove all 
non-adherent cells. Kinetic LPS stimulations were conducted on day 9 of cell culture. 
Bone marrow from C57BL/6 mice (Harlan Laboratories, UK) was differentiated for 10 d 
in granulocyte-macrophage colony-stimulating factor (4% (vol/vol) J588 myeloma cell 
supernatant) or for 7 d in M-CSF (20% (vol/vol) L929 mouse fibroblast supernatant) in 
typical media preparations for the preparation of BMDMs.  
Reagents and Treatment Conditions 
In all experiments, monocytes were stimulated with 1 µg/ml of E. coli 055:B5 
Lipopolysaccharide (LPS) (Sigma) for indicated time periods. In the case of re-
stimulation experiments, cells were initially stimulated with 1µg/ml of LPS and then re-
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stimulated with additional 1µg/ml of LPS without washing the media.  All inhibitors used 
in the study were applied one hour prior to LPS treatments in following concentrations; 1 
µM/ml MG132 (474790, Calbiochem), 10µM/ml U0126 (V1121, Promega), 10 µM/ml 
SB 202190 (152121-30-7, Sigma), 50 µM/ml 5,6-Dichlorobenzimidazole 1--D-
ribofuranoside (DRB) (D1916-10MG, Sigma) 10 µM/ml of IKK Inhibitor III (BMS-
345541, Calbiochem), and 25 µM LY294002 (440202, Calbiochem).    
Chromatin Immuno-precipitation (ChIP)  
ChIP was performed using a modification of the Millipore/Upstate protocol 
(MCPROTO407). In brief, a total of 1x10
7
 cells were fixed in 1% formaldehyde (F79-
500, Fisher) for 10 min at room temperature. Cross-linking was inhibited by addition of 
glycine to a final concentration 0.125 M. Cell pellets were washed twice with ice cold 
PBS and resuspended in SDS Lysis Buffer (1% SDS, 10 mM EDTA, 50 mM Tris, pH 
8.1) supplemented with 1 µg/ml Aprotinin (A6279-5MG, Sigma), 1µM 
phenylmethylsulfonyl fluoride (PMSF) (93482, Fluka), and 1 µg/ml Leupeptin (L9783-
5MG). Samples were sonicated (to generate DNA fragments of 250 base pairs (bp) 
average length) on ice using a Fisher Scientific Sonic Dismembrator (Model 100), as 
follows: 325 strokes at 100% power followed by 75 stokes at 50% power and centrifuged 
at 12000 RPM for 10 min. Chromatin from 5x10
6
 cells was diluted 7-fold in ChIP 
Dilution Buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, 
pH8.1, 167 mM NaCl), pre-cleared with protein Agarose/Salmon Sperm DNA beads 
(Protein G Agarose, 16-201 Millipore, Protein A Agarose 16-157 Millipore; IgM A4540 
Sigma-Aldrich) for 30 min at 4°C, and centrifuged at 10,000 RPM for 2 min. Chromatin 
supernatants were incubated at 4°C overnight with respective antibodies (Table 1). 
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Aliquots for INPUT and non-specific IgG control samples were included with each 
experiment. Samples were precipitated using 40 µl of protein agarose beads, depending 
upon specific antibody requirements (Table 1) at 4°C for 2 hours, and subsequently 
washed with following solutions: once with Low-Salt Buffer (0.1% SDS, 1% Triton X-
100, 2mM EDTA, 20 mM Tris-HCl, pH 8.1, 150 mM NaCl), once with High-Salt Buffer 
(0.1% SDS, 1% Triton X-100, 2mM EDTA, 20 mM Tris-HCl, pH 8.1, 550 mM NaCl), 
once with LiCl Wash Buffer (0.25 M LiCl, 1% IGEPAL-CA630, 1% deoxycholic acid, 
1mM EDTA, 10 mM Tris, pH 8.1), and twice with TE Buffer (10 mM Tris-HCl, 1 mM 
EDTA, pH 8.0). Immunocomplexes were eluted in two stages for 30 min and 15 min at 
65°C with 260 µl and 140 µl of ChIP Elution Buffer (1% SDS, 0.1M NaHCO3), 
respectively. To reverse the cross-linking, eluted samples were treated with 16 µl of 5 M 
NaCl and subsequently incubated at 65°C for ≥4 hours. DNA was purified using a 
GeneJET PCR Purification kit (Fermentas,  #K0702). Primer pairs against various 
regions of human and murine genes were designed using the PrimerQuest software 
available at the Integrated DNA technologies website (Tables 2-4). The size of the PCR 
products range between 80 and 150 bp. Twenty microliter qPCR reactions containing 2x 
Maxima SYBR Green/ROX qPCR Master Mix (K0223, Fermentas), 250 nM of primers, 
and 3 µl of precipitated DNA were set up in Fast 96-Well Reaction Plates (4346907, 
Applied Biosystems). qPCR reactions were carried out in a StepOnePlus Applied 
Biosystems  Real Time Instrument.  Fold enrichment was calculated based on Ct as 2
(Ct)
,
 
where Ct = (Ct Input – Ct IP). Final enrichment values were adjusted by subtraction of the 
nonspecific IgG antibody binding.  
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Table 1. Antibodies used for ChIP and Western Blot Analyses  
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Table 2. Human IL1B ChIP primer sequences  
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Table 3. Human TNF ChIP primer sequences  
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Table 4. Human JUNB and HIST1H4K ChIP primer sequences  
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Table 5. Murine Il1b and Tnf ChIP primer sequences  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RNA Expression Analyses   
1x10
6
 cells were plated into 6-well plates (353846, FALCON).  Following treatments 
cells were transferred into 1.5 ml tubes and centrifuged at 3500 RPM for 3 min at room 
temperature. The cell pellets were resuspended in 500 µl of TRIzol reagent (15596-026, 
Invitrogen). After addition of 170 µl of Chloroform (C606-1, Fisher) samples were 
vortexed, incubated at room temperature for 15 min, and centrifuged for 15 min at 13000 
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RPM in 4°C chilled centrifuge. Aqueous layer was removed, combined with equal 
volume of Isopropanol (BP2632-4, Fisher), 1 µl of Glycogen (9510, Ambion), and 
centrifuged for 10 min 13000 RPM at 4°C. Sample pellets were washed with 500 µl of 
75% Ethanol (111ACS200, Pharmaco-AAPER) and centrifuged for 10 min in room 
temperature at 14000 RPM.  Air-dried pellets were resuspended in 30 µl of RNAse free 
water and subjected to DNAse treatments using Turbo DNA-free reagents (AM1907, 
Ambion) according to the manufacturer instructions in order to eliminate genomic DNA 
contamination. RNA was converted to cDNA using GoScript Reverse Transcription 
System (A5001, Promega). Relative expression levels were calculated using Ct 
method using B2M and 18srRNA as an endogenous controls.  In certain experiments 
RNA was directly subjected to an RT-PCR utilizing the Access RT-PCR system (A1250, 
Promega).  
Transfection Constructs  
Luciferase reporter XT-Luc IL1B, wild type IRF8 and mutant IRF8Y211F were as 
described (Unlu et al., 2007). Expression plasmids for wild-type C/EBP and the 
truncated C/EBPSPL, were constructed and characterized as reported (Tsukada et al., 
1994). Expression plasmids expressing wild-type Spi1 and the dnSpi1 deletion mutant 
were constructed as described (Galson et al., 1993; Kominato et al., 1995). The MHCB-
Luc reporter is as described (Mitchell and Sugden, 1995; Yoshida et al., 2004). 
 
 
 
 
39 
 
Table 6. mRNA analyses and qPCR primer sequences  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transient Transfections 
293 cells were seeded into 24 well plates to 60-70% confluency. Reporter and expression 
plasmids were transfected into 293 cells with FUGENE 6 Transfection Reagent 
(11814443001, Roche) at 3 μl of reagent per μg of DNA, according to the manufacturer’s 
instructions. Individual expression vectors were transfected as follows: 0.05 μg of Spi1 
and 0.1 ug of TRAF6, IRF8, C/EBP, and NF-B into 24 well plates containing 500 µl 
of media. Total amount of transfected DNA was maintained constant for each experiment 
by addition of empty vector. Endogenous IL1B studies were conducted in 6 well culture 
plates with the amount of transfected material adjusted 3 fold.  
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Luciferase Assays 
At 24 hours after transfection, cells were lysed with 60 l of 1X cell lysis buffer in each 
well (24 well plate) and shaken for 20 min at RT. 20 l of supernatant from each well 
was used for luciferase assay using Luciferase Assay System (Promega E1501) and 
analyzed by Veritas Microplate Luminometer and Software.  
Chromatin Conformation Capture (3C)  
In brief, a total of 1.5x10
6
 cells were fixed in 2% formaldehyde (F79-500, Fisher) for 10 
min at room temperature. Cross-linking was inhibited by addition of glycine to a final 
concentration 0.125 M. Cell pellets were collected into 15 ml Falcon tubes and washed 
twice with ice cold PBS and resuspended in Lysis Buffer (10mM Tris-HCl pH 8.0, 10 
mM NaCl, 0.2% NP-40, supplemented with 1 mM PMSF, and protease inhibitor cocktail 
(Sigma) in 1:500 dilution) on ice for 90 min. Samples were centrifuged at 1800 rpm for 5 
min, resuspended in 900 μl of 1.2xNEB4 (diluted with 0.3% SDS), and transferred into 
1.5 ml Eppendorf tubes. Nuclear lysates were incubated for 1 hr at 37°C with moderate 
vortexing. 180 μl of Triton X-100 (final concentration of 1.8%) was added and samples 
were incubated for additional 1 hr at 37°C. Portion of chromatin (1 ug) was removed and 
treated overnight with MfeI (40 Unit) at 37°C. Lysates were treated with 1.6% SDS and 
incubated 60°C for 20 min. 47.5 μl of Lysates were used for ligation reaction (40 μl 10% 
Triton X-100, 40 μl ligase buffer (10x), 270 μl H2O, 2.5 μl T4 DNA ligase) that was 
carried out for 16 hours at 16°C. Next, 100 µg/ml of proteinase K was added to samples 
that were subsequently incubated overnight at 65°C. Next day, samples were treated with 
RNase A (0.5 µg/ml) for 30 min at 37°C and DNA was extracted. PCR products were 
amplified using following primers 1’: 5’-GGG GCC TCC AAA TCA CTA AGC-3’, 2: 
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5’-GCA TTG CCC CAT GGC TCC AAA AT-3’, 3’: 5’-TCT CTA CCT TGG GTG CTG 
TTC TC-3’, 4: 5’-CCG CTG TAA CGG GCA AAA GTT TC-3’. GoTaq PCR Core 
System I (M7660, Promega) was used for PCR analyses.  
Site Directed Mutagenesis 
XT-Luc binding site mutation reporter constructs: C/EBP I region binding site (XT-I 
c/g-Luc), NF-ΚB site at position -300 (XT-300B-Luc), and the double I(c/g)/-300B 
were generated using QuickChange XL Site-Directed Mutagenesis Kit (Stratagene 
200516) using appropriately mutated primer sequences. Primer pairs listed in were used 
for site directed mutagenesis. The XT-I(c/g)-Luc plasmid was used as a template for 
generation of the double mutant (I region/-300 NF-B site) construct. XT-300mut (F)/(R) 
were used as primers.  
 
Table 7. Site-directed mutagenesis primer pairs 
 
IL1B enhancer I region XT-I (c/g)-Luc primer pairs: 
 
I (c/g) F 
5’CTGTGGAGACTGTTAGGTCAGGGGGCATTGC3’ 
 
I (c/g) R 
5’GCAATGCCCCCTGACCTAACAGTCTCCACAG3’ 
 
NF-B site (-300) mutation 
 
XT-300 F 
5’AACATTCTTCTAACGTGTGAAAATACAGTATTTTAATGTGGACATC3’ 
 
XT-300 
R 
5’GATGTCCACATTAAAATACTGTATTTTCACACGTTAGAAGAATGTT3’ 
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RESULTS 
 
IL1B and TNF mRNA are Differentially Expressed in Monocytes 
 Steady-state mRNA kinetic profiles of the IE genes IL1B and TNF in a human cell 
line (THP-1) and human primary macrophages (hPBMCs), as well as a murine cell line 
(RAW 264.7), revealed differences in the transcriptional responses of these two genes. 
The expression profiles were assessed by various methods including agarose gel 
resolution of reverse transcribed (RT) PCR products (Figure 6) and Real Time 
Quantitative PCR (RT-qPCR) (Figure 7). TNF undergoes rapid induction and significant 
transcriptional shut down within a few hours of LPS treatment. In contrast, IL1B is also 
rapidly induced and then decreased, but is not completely switched off, continuing 
expression for many hours post-stimulation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. IL1B and TNF expression in LPS stimulated THP-1 cells. 
THP-1 cells were stimulated with 1g/ml of LPS for indicated time points and 3% agarose gels were used 
to resolve the band pattern of amplified products. Following a strong transient phase, the expression of 
IL1B decreases but is sustained for hours post stimulation. In contrast to IL1B, expression of TNF 
terminates 3 hours post stimulation after its initial transcriptional response. Increased dosage of LPS (5 
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g/ml and 10 g/ml) causes amplified and lengthened initial expression of the IL1B and TNF genes. The 
amplification of beta actin serves as a loading control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Comparison of IL1B and TNF Transcription in Monocytes. 
Steady-state mRNA kinetics for IL1B and TNF transcripts in LPS stimulated THP-1, RAW264.7, and 
hPBMCs. Transcript levels were normalized to beta 2-microtubulin (B2M), and then as the ratio of amount 
in resting vs. LPS-treated cells. Circles denote mRNA levels for primary LPS challenge. Squares show 
transcript levels following re-stimulation as indicated by arrows. Data used for generation of this figure are 
presented in Appendix A. 
 
 
Transient expression patterns for these two genes are reflective of their 
transcription status because of the short mRNA half-life mediated by AU-rich element 
(ARE) degradation (Chen et al., 1994; Fenton et al., 1988). ARE, localized within the 3’ 
untranslated region of many pro-inflammatory genes influence their rapid degradation 
and/or repress their translation. Inhibitory properties of these elements are conveyed by 
the recruitment of ARE-binding proteins, which utilize various mechanisms for targeting 
and eliminating accumulating messages (Wu and Brewer, 2012). The stability of mRNA 
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is an important feature shaping the classical transient temporal pattern of the IE pro-
inflammatory gene expression. As Figure 6 reveals, an increased amount of LPS 
stimulus (from 5 to 10 g/ml) caused a more robust and prolonged transient expression 
pattern of both genes.  
Additional differences between these two genes were also apparent in resting 
human monocytes, in which basal levels of predominantly full-length unspliced TNF, but 
not IL1B, transcripts were detected (Figure 8A). Kinetic mRNA profiles within the first 3 
hours revealed that TNF transcript production is 30 minutes faster than that of IL1B 
(Figure 8B). 
A          B  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Analysis of IL1B and TNF mRNA splicing efficiency and expression kinetics in resting and 
stimulated THP-1 monocytes.  
The IL1B and TNF gene expression data was normalized to the endogenous 18s ribosomal RNA (18s 
rRNA) gene expression. (A) qPCR data comparing the splicing efficiency of IL1B and TNF mRNA in 
resting THP-1 cells. cDNA samples were prepared using random primer directed reverse transcription. 
Selective amplicons were designed for the detection of un-spliced/primary (primers targeting sequence 
within a single intron) and spliced (spanning the last intron and splice site) transcripts. (B) qPCR analysis 
of LPS-treated human THP-1 monocytes (High resolution 0-3 h kinetics). 
45 
 
 
 
Semi-quantitative analysis revealed that approximately 20% of these rapidly 
accumulated TNF messages appear to be incompletely processed primary transcripts 
(Figure 9A, B, C). 
 
A 
 
 
 
 
 
 
 
 
 
 
 
 
         
 
 
 
 
 
 B                               C 
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Figure 9. Un-spliced TNF transcripts in LPS treated THP-1 cells and hPBMC. 
(A) IL1B and TNF mRNA splicing efficiency in LPS stimulated THP-1 cells and hPBMCs, as measured by 
comparing the total (amplicons designed within a single exon containing both spliced, and un-spliced 
products) vs. un-spliced/primary (within single intron) transcripts. The qPCR data are normalized to the 
endogenous 18srRNA levels. Shown are 3% agarose gels resolving the presence of spliced and/or un-
spliced mRNAs of IL1B (top gel) and TNF (bottom gel) genes expressed in LPS treated THP-1 cells (B) 
and human primary macrophages (C). Black labels indicate the 500 bp reference marks and the sizes of 
properly spliced mRNAs (149 for IL1B, and 114 for TNF). The red numbers denote the expected size of the 
intron-retaining unspliced transcripts (867bp for IL1B and 415bp for TNF). Retention of the intron 
sequence within the TNF gene causes a 301 bp shift and creates an additional lower intensity band at the 
415 bp mark.  
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 RNA polymerase II (Pol II) ChIP-qPCR was employed in order to directly 
measure the transcriptional status of IL1B and TNF in monocytes. Series of primer pairs 
scanning throughout the promoter proximal regions and structural parts of the genes were 
designed to accurately characterize the binding enrichment of Pol II and various factors at 
the IL1B and TNF loci (Figure 10A).  
 
A 
 
 
 
 
 
 
 
B        
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Figure 10. Schematic representation of ChIP-qPCR amplicons and generation of the data profiles for 
resting (0h), 1h, and 5h LPS treated THP-1 cells. 
(A) Schematic of IL1B and TNF gene structures showing exons (solid boxes), positions of ChIP amplicons 
(midpoint relative to TSS), and important transcription factor binding sites (C: C/EBP, : NF-κB, and S: 
Spi1) within regulatory regions (open boxes). (B) Illustration of a sample Pol II ChIP used for generation of 
a representative diagram. Each colored line tracing the ChIP enrichment bars, represents a specific LPS 
treatment time point 0h (black), 1h (red), and 5h (green). This color-coding is used in all figures that 
contain similar kinetic ChIP data. The enrichment values were normalized to the input DNA in all ChIP 
experiments. ChIP data presented are representative of at least 2 independent experiments.  
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The bar graphs obtained from ChIP-qPCR experiments were used to generate the 
diagrams that represent the average enrichment data sets. Figure 10B illustrates a tracing 
pattern for a sample Pol II experiment. Pol II occupancy kinetics, particularly in the THP-
1 cells (Figure 11), mimic the respective steady-state mRNA profiles confirming that the 
sustained expression of IL1B shown in Figure 11 is a result of a continuous polymerase 
engagement and not necessarily an increase in mRNA stabilization.  
 
 
 
 
 
 
 
 
 
 
Figure 11. Pol II occupancy at the il1b and tnf loci. 
Pol II ChIP throughout the il1b and tnf loci in resting (black), 1h (red), and 5h (green) LPS stimulated THP-
1, RAW264.7, and hPBMC cells. Vertical gray bars locate the positions of important gene landmarks. 
These include TATA box and the canonical Pol II pause position (approximately 30 bp upstream and 50 bp 
downsteam of TSS, respectively). Data used for generation of this figure are presented in Appendix B. 
 
Further kinetic analysis of the transient phase of THP-1 cell gene activation 
revealed a 15 minute delay in Pol II recruitment to IL1B (Figure 12), consistent with the 
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observed 30 min delay seen in mRNA profiles (Figure 8B). Increased Pol II binding at 
the TNF promoter was detected as early as 15 min post-stimulation  (Figure 12). Of note, 
the transient nature of Pol II enrichment in RAW264.7 cells and human primary 
macrophages is less apparent due to the prolonged early phase of IL1B and TNF 
transcription in these cells (Figure 7).  
 
 
 
 
 
 
 
 
Figure12. Kinetic ChIP analysis of Pol II recruitment to the IL1B and TNF gene promoters. 
Pol II recruitment was measured at the promoter region and a downstream site for IL1B and TNF in resting 
or LPS stimulated monocytes. The indicated time points underneath the graph correspond to the LPS 
treatment kinetics used for the ChIP assay.  
 
I next asked, whether the observed differential shutdown of these two immune 
genes contributes to their ability to be resistant to reinduction (tolerized), when exposed 
to a secondary LPS stimulus. A previous report argued that murine Ilib and Tnf are 
refractory to reactivation due to a plethora of intrinsic immuno-protective mechanisms 
commonly recognized as endotoxin tolerance (Foster et al., 2007). Endotoxin tolerance 
results in a decreased responsiveness of certain rapidly-induced monocyte genes to 
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repeated LPS stimulation. In my reactivation experiments, cell cultures were stimulated 
with LPS for indicated times with an equal dose of secondary LPS (Figure 7, arrows and 
boxes) administered for 2.5 hours to unwashed cultures, prior to assay (Figure 7, dotted 
lines). In agreement with the earlier report, my data indicate that tnf genes are tolerized, 
so that once activated they cannot be re-expressed by additional LPS treatment. In 
contrast to that report, transcription of il1b remained significantly inducible after repeated 
LPS exposure, as shown in murine and human cell lines and human primary macrophages 
(Figure 7). Additional experiments revealed that increased LPS concentrations used for 
secondary stimulation (4.5 g/ml and 9.5 g/ml) did not affect the tolerant nature of TNF. 
Figure 13 illustrates and further validates that TNF is rapidly shut down at 3 hours post 
stimulation and does not reactivate with subsequent LPS stimulus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. TNF expression is desensitized in THP-1 cells.  
Cell cultures were initially stimulated with a low amount of LPS (0.5 g/ml) for indicated times. Two 
increased doses of secondary LPS (4.5 g/ml or 9.5 g/ml as indicated) were administered for 2.5 hours to 
unwashed cultures, prior to assay. 3% agarose gel was used to resolve the RT-PCR products.  
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Pol II Pausing and the P-TEFb:NELF Axis Contribute to Differential 
Transcriptional Shutdown of IL1B and TNF 
Pol II recruitment and pre-initiation complex assembly at IE gene promoters has 
recently been associated with the presence of pre-bound, paused, Pol II (Gilchrist et al., 
2010; Gilchrist et al., 2008; Guenther et al., 2007; Kininis et al., 2009; Min et al., 2011; 
Muse et al., 2007; Rahl et al., 2010; Zeitlinger et al., 2007). These genes are associated 
with immediate responsiveness to stimuli, with rapid expression dependent on the release 
of Pol II from its pre-induced paused state (Wu and Snyder, 2008). In this way, pre-
loaded polymerases likely facilitate synchronized and rapid transcription of IE genes. 
Since the il1b and tnf genes are transcribed almost instantly in activated monocytes, Pol 
II enrichment on their promoters was examined. In agreement with a previous report for 
murine macrophages (Adelman et al., 2009), TNF exhibited a significant Pol II presence 
approximately 50 bp downstream of the TSS in resting THP-1 cells and human primary  
macrophages (Figure 11). Surprisingly, less preloaded Pol II was detected on IL1B than 
on TNF in unstimulated monocytes. LPS activation caused increased levels of Pol II 
signal at the promoter proximal region and throughout the transcribed regions of both 
genes, consistent with elongating Pol II. Following cell activation, a large increase of 
paused Pol II at the IL1B promoter was evident in all three cell types (Figure 11). A more 
precise fragmentation of genomic DNA and appropriate design of qPCR amplicons are 
vital components of ChIP studies that influence the final resolution of the enrichment 
data. My initial ChIP experiments using a sparsely designed qPCR amplicons yielded 
useful and consistent information about the kinetic associations of various molecules but 
lacked the spatial resolution of their binding. Figure 14 shows a few samples of low-
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resolution ChIP experiments used to detect recruitment of various factors to the IL1B and 
TNF genes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Low resolution ChIP profiles for IL1B and TNF. 
Illustrated are low-resolution ChIP profiles for Pol II S5P CTD, and the transcription elongation factors 
NELF and P-TEFb. Association of these individual molecules with the IL1B and TNF was measured at 
indicated LPS treatment time points (0h-black, 0.5h-red, 5h-green). These data can be compared to another 
independent experiment (Figure 17) that was executed using high-resolution primers depicted in Figure 
15.  
In order to improve the spatial data quality I designed a new set of high-density 
qPCR amplicons that selectively target the promoter proximal region of IL1B and TNF 
genes (Figure 15).  As Figure 16 illustrates, the sonication method used in this study 
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yielded DNA fragments with average length of 250-300 bp. Statistical evidence, as well 
as experimental testing revealed that such fine chromatin fragmentation and appropriate 
size of qPCR amplicons provide sufficient resolution for qPCR-ChIP analysis used in this 
study (Xie et al., 2008).  
 
 
 
 
 
 
 
Figure 15. High-density qPCR-ChIP amplicons encompassing the promoters of the IL1B and TNF 
genes.  
Illustrated is a series of qPCR amplicons, average length of 80 bp, designed for high resolution ChIP 
analyses.  
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Analysis of the chromatin fragmentation.  
Shown is a 1.5% agarose gel analysis of the sonicated genomic DNA isolated from THP-1 cells. The DNA 
fragments obtained by this sonication method have an average length of 250-300 bp. 
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Figure 11 revealed a differential spatial distribution of bound Pol II complexes 
for IL1B vs. TNF, represented by two promoter-proximal peaks located approximately 
150 base pairs apart for IL1B, and a single peak for TNF. The single Pol II peak on TNF 
(centered at +57) and the first on IL1B (centered at +36) map near the TSS. This is 
consistent with a paused polymerase (Core and Lis, 2008). Analysis of TBP revealed an 
expected peak upstream of the Pol II complexes located to the TATA box of both genes. 
Differential amounts of TBP binding between IL1B and TNF in resting and induced cells 
agrees with and further supports differential Pol II pre-association for these genes 
(Figure 17). TNF contains significant amount of pre-bound TBP in resting monocytes 
and its levels further increase upon LPS stimulation. On the other hand IL1B lacks pre-
bound TBP and its de novo recruitment is primarily dependent upon LPS stimulus 
(Figure 17).  
JunB, an IE gene known to have pre-associated promoter-proximal Pol II (Aida et 
al., 2006; Fujita et al., 2009; Muse et al., 2007) and HIST1H4K, encoding a constitutively 
expressed “housekeeping” gene, Histone 4, whose Pol II levels remain constant in resting 
and LPS treated THP-1 cells serve as controls (Figure 18). 
During induction of IE genes, Pol II transitions from paused into an elongating 
polymerase in order to generate mRNA intermediates. An actively elongating Pol II is 
associated with characteristic post-translational modifications and a presence of unique 
proteins. I have analyzed several of the distinguishing features in order to define changes 
that correspond to the LPS induced release of paused Pol II in stimulated monocytes. 
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Figure 17. Distribution of factors relevant to differential transcriptional regulation. 
ChIP for factors related to Pol II initiation and elongation at IL1B and TNF loci in THP-1 cells was 
measured at distinct time points in resting (black), 1h (red) and 5h (green) LPS stimulated THP-1 cells. 
Enrichment profiles for TBP, S5P CTD Pol II, S2P CTD Pol II, NELF, P-TEFb and Pol II (using 
alternative 8WG16 antibody) are shown. A purple dotted line in the 8WG16 (bottom panels) experiment 
represents a 1-hour time point, in which THP-1 cells were pre-treated with the P-TEFb inhibitor 5,6-
dichloro-1-beta-D-ribofuranosylbenzimidazol (DRB) prior to stimulation with LPS. Data used for 
generation of this figure are presented in Appendix C.      
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Figure 18. ChIP analysis for Pol II enrichment at control genes JUNB and HIST1H4K. 
Pol II occupancy kinetics on JUNB and HIST1H4K genes in resting (black), 1h (red), and 5h (green) LPS 
stimulated THP-1 cells. Data (upper panels) used to generate Pol II kinetic profiles are shown in the lower 
panels.  
 
The carboxy-terminal domain (CTD) of the RPB1 subunit of mammalian Pol II 
containing 52 tandem heptapeptide repeats with the consensus sequence YSPTSPS, was 
demonstrated to be differentially phosphorylated in paused vs. actively elongating Pol II. 
Phospho-serine 5-modified CTD (S5P) locates primarily to the upstream regions of genes 
as part of engaged, but stalled, Pol II. The cyclin-dependent kinase 7 (CDK7) component 
of the general transcription factor TFIIH mediates this phosphorylation (Egloff and 
Murphy, 2008), which aids in the process of methylguanosine cap addition to the 5’ end 
of nascent mRNAs (Brookes and Pombo, 2009). I observed that the enrichment of S5P 
polymerase is confined to the 5’ promoter proximal regions and decreases throughout the 
gene bodies of IL1B and TNF (Figure 17). S5P Pol II ChIP also revealed two 5’ proximal 
59 
 
peaks, supporting the presence of two Pol II complexes at the IL1B promoter. 
Phosphorylated CTD serine 2 (S2P) marks elongating polymerases and mediates the 
recruitment of various factors responsible for proper mRNA co-transcriptional 
processing, including splicing and 3’ poly-A addition (Buratowski, 2003). Pol II S2P 
ChIP confirmed the presence of elongating polymerase in LPS stimulated monoctyes, 
having a characteristic enrichment profile in which the signals increased towards the 3’ 
end of both genes. Negative elongation factor (NELF) interacts with paused polymerases 
and contributes to stalling by a proposed interaction with nascent RNA emerging from 
Pol II via its RNA recognition motif (Gilchrist et al., 2008; Wu et al., 2003; Yamaguchi 
et al., 2002). The negative effects of NELF are relieved by positive transcription-
elongation factor-b (P-TEFb), a complex of CDK9 and cyclin T1. By simultaneously 
phosphorylating NELF and the S2P CTD, signal dependent recruitment of PTEF-b leads 
to Pol II release from a paused state into one of elongation during pro-inflammatory 
responses in murine macrophages (Hargreaves et al., 2009). Figure 17 shows kinetic 
profiles for various indicators of transcription elongation following LPS treatment of 
THP-1 cells. Increased binding of NELF to paused Pol II at the TNF promoter is 
diminished within an hour of LPS stimulation. As induced transcription concludes, 
around five hours post stimulation, NELF binding to TNF returns to pre-stimulation 
levels. NELF ChIP for the IL1B promoter revealed a distinct binding pattern with 
increased enrichment values at later time points. I did not see significant NELF 
enrichment in unstimulated cells. Although surprising at first, this supports the low level 
of paused Pol II in resting cells, and its existence in LPS stimulated monocytes. P-TEFb 
is coordinately recruited to the promoters of both genes. Treatment of cells with the 
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P-TEFb inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazol (DRB) caused an 
increase in Pol II at the proposed pause sites, as confirmed by an alternative Pol II 
antibody (8WG16), confirming the significance of P-TEFb in inducible control of IL1B 
and TNF (Figure 17). It has been reported that the 8WG16 antibody was specifically 
designed for detection of non-S2P phosphorylated CTD tail of Pol II (Brookes and 
Pombo, 2009). My data correspond to an expected 8WG16 ChIP enrichment profile for 
the paused genes with a peak at the promoter proximal region, which drops off towards 
the 3’ end (Figure 17). Kinetic differences in P-TEFb recruitment to IL1B vs. TNF were 
also observed in LPS treated monocytes. In contrast to TNF, a rapid P-TEFb recruitment 
is prolonged (although decreased) on IL1B at 5 hours post stimulation. This provides an 
explanation for the delayed/sustained phase of IL1B expression as compared to that of 
TNF. The data argue for a kinetic interplay between positive (P-TEFb) and negative 
(NELF) pausing factors that may contribute to the differential post-induction decrease 
and shutdown of these two immediate-early genes. ChIP analysis of Pol II dynamics was 
also expanded to the murine il1b and Tnf genes. Similar profiles of positive and negative 
elongation factors and the Pol II modifications were observed for RAW264.7 cells 
(Figure 19) as well as bone marrow derived macrophages (BMDM) (Figure 20). As 
revealed in steady state mRNA analysis, the initial phase of Il1b and Tnf transcription is 
prolonged (Figure 7). Since the Pol II binding profiles mimic this transcriptional 
phenomenon, the transient nature of Pol II enrichment in these cells is less apparent 
(Figure 19, 20). I observed that Pol II is pre-loaded on Tnf in similar fashion as in its 
human counterpart. Following LPS treatment, rapidly recruited P-TEFb induces Tnf 
elongation by inducing NELF discharge and S2P of Pol II CTD.  
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Figure 19. Average profiles of factors relevant to differential transcriptional regulation in LPS-
treated RAW264.7 cells. 
ChIP for factors related to Pol II initiation and elongation at Il1b and Tnf loci in RAW264.7 cells was 
measured at distinct time points in resting (black), 1h (red) and 5h (green) LPS stimulated THP-1, cells. 
Enrichment profiles for Pol II, TBP, S5P CTD Pol II, S2P CTD Pol II, NELF, P-TEFb and Pol II (using 
alternative 8WG16 antibody) are shown. A purple dotted line in the 8WG16 (bottom-most panels) 
experiment represents a 1-hour time point, in which RAW264.7 cells were pre-treated with the P-TEFb 
inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazol (DRB) prior to stimulation with LPS. Data used 
for generation of this figure are presented in Appendix D.      
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Figure 20. Average profiles of various factors relevant to differential transcriptional regulation in ex 
vivo-differentiated LPS-treated BMDM.  
ChIP for factors related to Pol II initiation and elongation at Il1b and Tnf loci in RAW264.7 cells was 
measured at distinct time points in resting (black), 4h (yellow) and 24h (blue) LPS stimulated ex vivo-
differentiated BMDM. Enrichment profiles for Pol II, S5P CTD Pol II, S2P CTD Pol II, and P-TEFb are 
shown. The bar graph ChIP enrichment data used for generation of this figure are presented in Figure 60.  
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Consistent with the THP-1 study, murine Il1b does not contain NELF-mediated 
paused Pol II complex in resting monocytes, and its induction relies on the de novo 
recruitment of Pol II. The characteristic peak of Pol II enrichment in the vicinity of TSS 
in LPS stimulated cells indicates a presence of rate limiting step controlling the release of 
stalled polymerase. As reported for THP-1 cells, P-TEFb mediates this transition in 
murine monocyte/macrophages (Figure 19, 20). 
 
LPS Triggers a Double Pol II Pause on IL1B 
Various ChIP binding profiles including total Pol II, S5P CTD Pol II, NELF and 
P-TEFb collectively revealed two pausing sites near the IL1B gene promoter. This 
prompted investigation of whether these two complexes are associated with either short 
aborted transcripts, or Pol II dwelling. High-density amplicons designed for ChIP 
(Figure 15) were used for RT-qPCR amplification of random primer-generated cDNA 
samples from resting and stimulated monocytes. Genomic DNA was used for the analysis 
of primer pair PCR efficiency (Figure 21). This technique provided sufficient resolution 
for measuring transcriptional activity of Pol II within the observed Pol II ChIP peaks. 
Amplicons specific for the DNA upstream of the TSS served as controls, registering 
negligible signals. Semi-quantitative transcription profiles revealed peaks of short 
transcripts corresponding to the sites of engaged, but stalled, Pol II (Figure 22). These 
data represent appropriate measurements of nascent transcript production by Pol II, as 
they convey consistent inducible and temporal expression patterns (Figure 22, upper 
panels). Production of these RNA intermediates is sensitive to inhibitor treatments 
(Figure 22, lower panels). 
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                                   Positions relative to TSS  
Figure 21. Analysis of promoter proximal qPCR amplicon efficiency.  
Genomic DNA from THP-1 cells was used to determine the amplification efficiency of a series of primers 
designed for ChIP-qPCR analysis as well as random primer generated cDNA analysis. For this analysis 10% of 
chromatin used for antibody precipitation, equal to 4x105 THP-1 cells was used.  
 
The inhibitors used for this experiment abolish activation of the transcription 
factors NF-B (MG 132) and C/EBPβ (U0126). While NF-B is the primary activator of 
TNF, both NF-B and C/EBPβ are required for efficient transcription of the IL1B gene, which 
is consistent with the inhibitor effects on mRNA levels shown in Figure 22. In agreement 
with observed Pol II ChIP data, the presence of basal transcription for TNF in unstimulated 
monocytes was further confirmed utilizing this technique. Data sets for TNF closely 
resembled the classically paused JunB gene (Figure 22). Since the second Pol II peak on IL1B 
was not associated with a significant level of nascent RNA signal, it is possible that these Pol 
II complexes represent resting/dwelling polymerases, and not the presence of two 
transcription initiation sites. Contrary to the inducible IL1B, TNF, and JunB profiles, the 
control HIST1H4K gene transcript amplification shows constitutive expression (Figure 22). 
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Figure 22. Steady-state mRNA kinetics for IL1B, TNF, and control gene transcripts in LPS 
stimulated THP-1 cells.  
cDNA prepared form THP-1 cells, stimulated with LPS at different time points and/or pre-treated with 
various inhibitors was subjected to qPCR analysis using high-resolution primers spanning the promoter 
proximal regions of IL1B and TNF. Transiently induced JUNB and constitutively expressed HIST1H4K 
were used as controls for this experiment. Black bar graphs located in the upper corners of the diagrams 
represent magnification of mRNA in unstimulated THP-1 cells due to the fact that their levels are 
extremely low (TNF) or absent (IL1B) in comparison to the 1.5h LPS activated monocytes. The inhibitors 
MG132 (blue bars) and U0126 (yellow bars) were used to inhibit the activation of transcription factors NF-
B and C/EBPβ. While NF-B is the primary activator of TNF, both NF-B and C/EBPβ are required for 
efficient induction of the IL1B gene.  The red bars represent samples that were pre-treated with the P-TEFb 
inhibitor DRB, which interferes with the transition of Pol II into transcription elongation.  
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Pol II S2P CTD Differentially Influences IL1B and TNF Endotoxin Tolerance 
Some IE cytokines have been associated with inhibitory mechanisms that prevent re-
expression upon secondary endotoxin stimulus (Foster et al., 2007). Prior attempts to 
explain this phenomenon by transcription suppression have failed to note that the 
expression profiles for these genes are highly transient. If transcription following 
secondary stimulation is not analyzed within a short time frame, the re-stimulation 
properties can be overlooked. In addition, usage of inconsistent doses of secondary LPS 
and washing of cells between primary and secondary endotoxin challenge may result in 
experimental variability and induce physiological stress to highly sensitive cells, 
respectively. In my experiments, Western blot analysis demonstrated that secondary 
stimulation of IL1B resulted in expression of 30 KDa proIL-1 precursor protein (Figure 
23). Strikingly, these results recapitulate an earlier report that in vivo injection of a 
sublethal dose of LPS into mice resulted in TNF, but not IL-1 tolerance, as assayed by 
kinetic protein analysis of serum (Zuckerman et al., 1991).  
 
 
 
 
 
Figure 23. Western blot depiction of the 30 KDa proIL-1 precursor protein.  
THP-1 cell were initially stimulated with 1 g/ml of LPS for indicated times and an equal dose of 
secondary LPS was administered for 3 hours to unwashed THP-1 cultures, prior to cell harvest and analysis 
of the proIL-1 expression. The chemiluminescent detection of secondary antibody was assayed using a 
molecular dynamics Typhoon 8600 phosphor/fluorescence imager.   
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Similarly, steady-state kinetic mRNA secondary stimulation revealed that IL1B 
transcription is not completely desensitized/tolerized (Figure 7). ChIP revealed a 
somewhat decreased, but significant, amount of Pol II at the promoter-proximal regions 
of both genes in 13 and 25 hour stimulated monocytes, with decreased signal downstream 
of the pause sites (Figure 24, 25). At 25 hours, Pol II occupancy within the gene body 
was slightly higher for IL1B, likely explaining the sustained transcriptional profile of the 
gene. NELF was co-localized with promoter bound Pol II on both genes (Figure 24). My 
data reveal that upon secondary stimulation, P-TEFb is re-recruited to the IL1B promoter, 
resulting in resumption and maintenance of transcriptional elongation by Pol II. This is in 
contrast to tolerized TNF, in which P-TEFb recruitment and S2P CTD levels are not 
increased in LPS re-stimulated cells (Figure 24).  
Re-stimulation experiments carried out at 13 hours revealed a similar but 
decreased response to a secondary LPS stimulus. This suggests that IL1B undergoes a 
degree of decreased LPS responsiveness within the first 13 hours of initial stimulation 
(Figure 25). As described in the Introduction, P-TEFb mediated phosphorylation of 
serine 2 within the CTD of elongating Pol II promotes recruitment of various splicing 
factors to ensure proper nascent mRNA processing. The fact that P-TEFb is recruited to 
IL1B and not TNF during secondary LPS exposures, prompted us to examine the integrity 
of transcripts produced in the reactivated THP-1 cells. 
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Figure 24. ChIP re-stimulation experiments at 25 hours.  
ChIP for S2P CTD Pol II, NELF, P-TEFb, and Pol II on IL1B and TNF during secondary LPS stimulation 
of THP-1 cells. The solid lines represent primary and dotted lines secondary LPS treatment of THP-1 cells 
at indicated times. Thin gray lines denote 1h LPS reference. Gene landmarks (gray bars) reveal the location 
of an additional important NF-B binding site (-300 bp) for IL1B. Solid blue lines denote ChIP data for 
primary LPS challenge harvested at 25 hours post simulation. Dotted blue lines show ChIP data for THP-1 
cells that were initially treated for 24 hours with LPS, and subjected to a re-stimulation for an hour prior to 
their fixation and harvest. Equal dosage of LPS (1 g/ml) was used in both, primary and secondary 
stimulation experiments. Data used for generation of this Figure are presented in Appendix E.  
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Figure 25. ChIP re-stimulation experiments at 13 hours. 
ChIP for S2P CTD Pol II, NELF, P-TEFb, and Pol II on IL1B and TNF during secondary LPS stimulation 
of THP-1 cells. The solid lines represent primary and dotted lines secondary LPS treatment of THP-1 cells 
at indicated times. Thin gray lines denote 1h LPS reference. Gene landmarks (gray bars) reveal the location 
of an additional important NF-B binding site (-300 bp) for IL1B. Solid blue lines denote ChIP data for 
primary LPS challenge harvested at 13 hours post simulation. Dotted blue lines show ChIP data for THP-1 
cells that were initially treated for 12 hours with LPS, and subjected to a re-stimulation for an hour prior to 
their fixation and harvest. Data used for generation of this Figure are presented in Appendix E.  
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Figure 26. qPCR-amplified random primer generated cDNA levels for IL1B and TNF following re-
stimulation.  
Primary stimulations are labeled as black bars while secondary treatments are shown as gray bars. Re-
stimulation time points are indicated above the respective gray bars (0.5h, 1.5h, and 3h). Equal dosage of 
LPS (1 g/ml) was used in all treatments.  The qPCR data are normalized to the endogenous 18srRNA 
levels. 
 
The analysis of a random primer (instead of polyA) generated cDNA products 
revealed a minor increase of TNF mRNA in secondary stimulated monocytes (Figure 
26). These messages are likely representing incompletely processed primary TNF 
transcripts that are generated by the low levels of P-TEFb deficient transcribing Pol II. I 
propose that the gene specific recruitment of P-TEFb serves as a regulatory step 
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mediating the escape form endotoxin tolerance. This mechanism ensures proper IL1B 
mRNA polyadenylation and processing, which is deficient during the re-stimulation of 
TNF gene. My results indicate that the low levels of sustained IL1B expression may 
maintain the gene sufficiently competent for secondary re-induction. These data argue 
that secondary induction of IL1B is a physiologically significant phenomenon that further 
distinguishes it from TNF.  
Contrary to previous studies (Chan et al., 2005; Foster et al., 2007; Yoza et al., 
2002) our re-stimulation experiments were conducted without washing of the monocytes 
between primary and secondary endotoxin challenge. Since some of these reports argued 
that both TNF and IL1B are incapable of re-activation, I decided to repeat their 
experimental set up and conduct a set of experiments in washed THP-1 cultures. As 
Figure 27 demonstrates, washing of monocytes prior to the secondary LPS treatments 
decreased expression of IL1B.  These experiments suggest that the washing step may 
impede function of cell surface TLR4-mediated receptor signaling.  
 
 
 
 
 
 
 
 
 
Figure 27. Washing of cells prior to re-stimulation abolishes IL1B expression.  
Cell cultures were initially stimulated with a low amount of LPS (0.5 g/ml) for indicated times. Two 
increased doses of secondary LPS (4.5 g/ml or 9.5 g/ml as indicated) were administered for 2.5 hours to 
washed or unwashed cultures, prior to assay. Three percent agarose gel was used to resolve the RT-PCR 
products.  
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LPS Stimulation of Monocytes Results in Dynamic Changes in Nucleosome 
Positioning and Modification on IL1B and TNF 
Nucleosome positioning plays a critical role in controlling the accessibility of 
promoters for transcription machinery, and genome-wide studies have shown that 
Drosophila and human promoters are commonly devoid of nucleosomes (Mavrich et al., 
2008; Schones et al., 2008). Stalled Pol II can serve as a physical barrier by preventing 
promoter-proximal nucleosome assembly and formation of repressive chromatin, thus 
enabling explicit gene regulation (Gilchrist et al., 2010). Additionally, it has been 
demonstrated that CpG-islands near gene promoters prevent nucleosome deposition and, 
therefore, can influence the competence of transcriptional responsiveness to TLR4 
stimulus (Ramirez-Carrozzi et al., 2009). It is interesting to note that IL1B and TNF do 
not contain a significant presence of CpG-islands in the vicinity of their promoters. To 
address the question of chromatin influence on these two genes, promoter nucleosome 
occupancy in resting and stimulated THP-1 monocytes, as well as a cell line that fails to 
express either IL1B or TNF (HEK293 pre-neuronal (Shaw et al., 2002)) and one that 
constitutively expresses only TNF (HUT102 cutaneous T lymphocyte), were examined 
by core histone 3 (H3) ChIP (Gilchrist et al., 2008; Schones et al., 2008). This provided 
sufficient resolution to obtain enrichment profiles for phased nucleosomes (Figure 28). 
Here I report +1 nucleosomes on both genes approximately 200 bp downstream of TSS. 
A similar observation was reported for the Hsp70 promoter in Drosophila (Petesch and 
Lis, 2008). The distribution of more weakly positioned nucleosomes, upstream of TSS 
was unique to each of the genes. I observed a significant depletion of promoter bound 
nucleosomes in 1 hour-stimulated monocytes, similar to that reported for activated genes 
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in yeast (Lee et al., 2004). The extent of nucleosome depletion was reduced in cells 
pretreated with the inhibitors selective for transcription factors associated with one or 
both of these genes (Figure 28).  
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Figure 28. Nucleosome positioning dynamics during IL1B and TNF induction. Depicted are spatial and 
kinetic histone 3 (H3) ChIP data for IL1B and TNF in resting (black), 1h (red), and 5h (green) stimulated 
THP-1 cells, as well as control Hut102 (pink line) and HEK293 (blue line) cells. Key nucleosomes are 
designated by position relative to the TSS (-2, -1, +1). The blue dotted line represents H3 ChIP for THP-1 
cells pre-treated with the NF-B inhibitor MG132 and the yellow dotted line denotes the U0126 (C/EBPβ 
inhibitor) treated THP-1 cell samples. Data used for generation of this Figure are presented in Appendix F. 
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I argue that this process is stimulation dependent, requiring specific factor 
recruitment. It is noteworthy that the IL1B nucleosome displacement is sensitive to both 
inhibitors, whereas TNF is almost exclusively affected by MG132, suggesting that 
C/EBP is specific to IL1B. Five hours post-stimulation, as the Pol II recruitment levels 
decline, depleted nucleosomes recovered, approaching initial enrichment levels for the +1 
nucleosome of TNF. In contrast, IL1B nucleosome depletion only exhibited a partial 
recovery. In addition, pre-treatment of cells with either inhibitor resulted in a striking 
increase in the -1 IL1B nucleosome, revealing an additional distinction from TNF. The 
presence of a uniquely phased -1 nucleosome within the NFR has been suggested to 
inhibit Pol II recruitment (Gilchrist and Adelman, 2012; Jiang and Pugh, 2009), but to 
our knowledge this is the first report indicating its role affecting inducible IE activation in 
human immune cells and may reflect loss of an important priming function for TNF. 
Figure 29 illustrates that the nucleosome eviction at IL1B and TNF promoter regions is 
likely mediated by the ATP-dependent histone remodeler SNF2/BRG1. ChIP data 
reveal a rapid recruitment of BRG1 to the promoters of both IE genes within 30 minutes 
of LPS treatment. The inducible BRG1 binding was prominent in vicinity of the IL1B and 
TNF promoters as compared to the structural part of the genes (Figure 29).  
In HEK293, IL1B and TNF nucleosomes were similarly positioned to those in 
THP-1, exhibiting higher levels, especially for the -1 nucleosome. Nucleosomes were 
similarly more abundant than in THP-1 for IL1B in Hut102, with higher levels for -2 and 
+1 nucleosomes. The constitutive expression of TNF in Hut102 revealed a depleted 
profile almost identical, but slightly higher, than that for 1 h stimulated THP-1 cells. 
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Figure 29. Nucleosome eviction at the IL1B and TNF promoter regions is likely mediated by the 
ATP-dependent histone remodeler SNF2/BRG1.  
Spatial and temporal occupancy of the SNF2/BRG1 complex at the IL1B and TNF genes was analyzed at 
indicated time points (0h, 0.5h 1h, 3h, 6h) following LPS treatment.  
 
To further understand the processes regulating the initially poised, but repressed, 
gene architectures and LPS induced transcriptional profiles, spatial-temporal distribution 
of several chromatin marks on IL1B and TNF was investigated (Figure 30).  LPS 
activation induced changes in nucleosome marks on these two genes. I observed the 
presence of high levels of H3K4me3 and low levels of H3K27me3 (Akkers et al., 2009) 
in monocytes that likely contribute to activity.  
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Figure 30. Histone modifications at IL1B and TNF in THP-1, Hut102, and HEK 293 cells.  
Depicted are spatial and kinetic ChIP profiles for Pol II, H3K36me3, H3k4me3, H3K9ac, and H3K27me3 
for IL1B and TNF in resting (black), 1h (red), and 5h (green) stimulated THP-1 cells, as well as control 
Hut102 (pink line) and HEK293 (blue line) cells. All panels are similarly scaled with respect to spatial 
distribution along each gene, permitting comparative localization. Data used for generation of this Figure 
are presented in Appendix G. 
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The initial permissive levels of H3K4me3 restricted to the vicinity of + 1 
nucleosomes do not show a significant increase during the initial one hour LPS treatment. 
To our surprise, enrichment of this mark revealed delayed kinetics and follows Pol II 
recruitment as shown by an increase at 5 hours post-stimulation. Higher levels of 
H3K4me3 at 5 h remain mostly focused at the promoter for IL1B, but spread throughout 
the downstream coding region of TNF. The distinct positional effect of H3K4me3 at the 
promoter versus the downstream coding region of genes has previously been observed for 
other genes (Barski, et al., 2007), and may be critical for differences between IL1B and 
TNF. Examination of other nucleosome marks for these two genes revealed that the 
relative level of H3K9ac within the coding region is relatively higher for IL1B than TNF 
at 5 h post LPS. Taken together, the relative levels of H3K4me3 and H3K9ac 
downstream of the TSS suggest a possible association with post-stimulatory tolerance for 
TNF. It is important to note that prior to stimulation, both genes are associated with low 
levels of H3K9ac that might play an additional role in maintaining the IL1B and TNF 
promoters in a transcriptionally poised state. The suppressive effect of the polycomb 
group proteins mediated by H3K27me3 directed transcriptional silencing is reversed by 
the H3K27 specific demethylase JMJD3 during macrophage inflammatory responses (De 
Santa et al., 2007). Loss of this repressive chromatin mark in Drosophila and embryonic 
stem cells, was shown to result in an increase in H3K27 acetylation, which was mediated 
by the acetyltransferase (HAT) activity of p300 and CBP (Pasini et al., 2010; Tie et al., 
2009). Our observations of depleted levels of H3K27Me3 encouraged us to examine the 
kinetic changes in H3K27Ac deposition and binding patterns of p300 on IL1B and TNF. 
As revealed in Figure 31, acetylation at lysine 27 was associated with an LPS-dependent 
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increase at the -2 nucleosomes, while a transient decrease was observed in H3K27Ac on 
downstream nucleosomes.  
Figure 31. Spatial-temporal distribution of H3K4me1 at IL1B and TNF in THP-1 cells.  
Depicted are spatial and kinetic ChIP profiles for H3K27ac for IL1B and TNF in resting (black), 1h (red), 
and 5h (green) stimulated THP-1 cells. The additional vertical gray bar located at the -3000 position 
upstream of TSS marks the IL1B enhancer region. Data used for generation of this Figure are presented in 
Appendix G. 
 
In agreement with these changes, p300 was transiently recruited upstream of the 
IL1B and TNF promoters by LPS (Figure 32). The Pol II elongation footprint marked by 
H3K36me3 (Henikoff and Shilatifard, 2011) revealed a consistent LPS-induced transient 
enrichment pattern increasing towards the 3’ end of both genes (Figure 30). In contrast to 
IL1B, significant levels of H3K36me3 were detected on the TNF locus in un-stimulated 
monocytes, further confirming constitutive basal activity. The spatial distribution of 
chromatin modifications at the IL1B and TNF loci were also assessed for Hut102 and 
HEK293 cells (Figure 30). Pol II levels and chromatin marks for TNF in Hut102 are 
consistent with the active transcription previously reported (Kronke et al., 1988), whereas 
IL1B is repressed in these cells and does not exhibit any positive indicators for either 
gene, while revealing inhibitory H3K27me3, absent in THP-1 (Figure 30). 
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Figure 32. ChIP analysis of p300 association at the IL1B and TNF genes.  
Shown is the LPS inducible association of p300 with the TNF and IL1B promoters as well as the 
IL1B enhancer. The NF-B inhibition using inhibitor MG132 abolishes p300 recruitment to both IE 
genes.  
TNF in Hut102 reveals significant levels of both H3K4me3 and H3K27me3, the 
so-called “bivalent” mark (Akkers et al., 2009), indicative of developmental, rather than 
transient IE induction, possibly responsible for the constitutive expression of this gene in 
these HTLV-1 infected malignant T cells. HEK293 does not show positive indicators for 
either gene, exhibiting non-bivalent inhibitory H3K27me3 on both. The inhibitory 
H3K27me3 extends throughout the entirety of both genes, but appears to be more focused 
over the coding region of TNF, while for IL1B, there is a greater level far upstream over 
the potent LPS enhancer near -3000, which binds C/EBP (Shirakawa et al., 1993). The 
analysis of spatial distribution of chromatin modifications at the IL1B and TNF locus was 
extended to the osteosarcoma MG 63 cell line. My data set (represented in the 
comprehensive Figure 33) reveals that MG 63 do not support expression of either one of 
the two IE genes.  
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Figure 33. Summary of the histone modification ChIP profiles for IL1B and TNF in THP-1, HEK 
293, Hut102, and MG63 cells. 
Illustrated are the summary profiles comparing nucleosome modifications for resting (black), 1h (red), and 
5h (green) LPS-treated human THP-1 cells with untreated HEK293 pre-neuronal cells (pink line), Hut102 
cutaneous T lymphocytes (orange line), and MG63 osteoblastic cells (blue line). Depicted are spatial and 
kinetic ChIP profiles for Pol II, H3K36me3, H3k4me3, H3K9ac, and H3K27me3, H3K9me1, H3K27ac, 
and H3K4me1 for IL1B and TNF. All panels are similarly scaled with respect to spatial distribution along 
each gene, permitting comparative localization. Data used for generation of this Figure are presented in 
Appendix G. 
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Active chromatin marks and levels of Pol lI in MG 63 cells largely differ from 
those of THP-1 monocytes. The inhibitory chromatin marks H3K9me1 and H3K27me3 
(Kouzarides, 2007) are prevalently distributed along the IL1B locus, further confirming 
its transcriptional suppression in MG 63 cell line.  
Lastly, the comparison of chromatin levels among the different cell lines enabled 
us to confirm that H3K9me1 is a likely indicator of transcriptional inactivation. Since 
IL1B and TNF are repressed in resting monocytes, I inquired whether H3K9me1 
contributed to the regulation of induction or the switching-down/off of these IEs. I 
observed that the high levels of H3K9me1 distributed throughout IL1B and TNF in 
resting monocytes were rapidly lost following LPS treatment and remained low even 
during the transcriptional shut-down, which was opposite to the kinetic pattern of 
H3K9ac ChIP (Figure 33). I conclude that the TLR4 dependent activation of IL1B and 
TNF caused replacement of the repressive H3K9me1 mark with a transcriptionally 
permissive acetylation (Gomes and Espinosa, 2010), likely contributing to the expression 
of both genes.  
 
Spi1 Mediates Monocyte-specific IL1B Expression 
The regulatory sequences driving IL1B and TNF expression contain numerous 
binding sites for various transcription factors that cooperatively contribute to the precise 
temporal and cell-type specific expression. Evaluation of the spatial-temporal distribution 
of selected transcription factors revealed that IL1B is dependent upon a different set of 
regulators than TNF. A major factor involved in genome-wide maintenance of the 
macrophage lineage is the ETS domain DNA binding factor Spi1 (Lawrence and Natoli, 
2011). In particular, recent genome-wide studies revealed a constitutive association of 
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Spi1, often with other signal inducible factors, at LPS responsive enhancers in murine 
macrophages (Ghisletti et al., 2010; Heinz et al., 2010). 
 Inducible IL1B transcription depends on a poised monocyte-specific enhancer 
that requires cooperative association of Interferon regulatory factor 8 (IRF8), Spi1, and 
non-tyrosine phosphorylated (NTP)-Stat1 (Unlu et al., 2007). In addition, Spi1 binding is 
also required at the IL1B promoter (Kominato et al., 1995). Consistent with earlier 
studies, ChIP revealed a robust constitutive association of Spi1 at the IL1B promoter and 
enhancer that persisted for an extended time post induction (Figure 34). In contrast, Spi1 
was significantly less abundant at the TNF promoter (Figure 34).  
 
 
 
 
 
 
 
 
Figure 34. ChIP analysis of Spi1 binding to the IL1B promoter and enhancer regions.  
Spi1 is constitutively present at the IL1B promoter (peaking at position -91) and enhancer (as measured at 
position -2976) regulatory regions (black bars). Its binding persists for up to 5 hours post LPS stimulation 
(pink bars). Spi1 is significantly less abundant at the TNF promoter. 
 
I hypothesized that in addition to its role priming enhancers, Spi1 binding at the 
IL1B promoter mediates the cell-type restricted transcriptional competency of this 
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pro-inflammatory gene. To examine the role of this “pioneer factor” during IL1B 
induction, transient transfection studies were carried out in HEK293 cells, which do not 
transcribe IL1B. Initial screens for transcription factor expression levels revealed the 
absence of Spi1 in these cells, as compared to THP-1 monocytes (Figure 35A). Since 
HEK293 do not express LPS-sensing TLR4 receptor, co-transfection of TNF receptor-
associated factor 6 (TRAF6) was used as a dominant-positive LPS surrogate in these cells 
(Figure 35B, illustration) (Wang et al., 2006).  
A     B 
      
 
 
 
Figure 35. RT-PCR analysis of the transcription factor expression levels in HEK 293 cells.  
(A) The 3% agarose gel showing the RT-PCR products for transcription factors in HEK293 and THP-1 
cells. The monocyte specific factors Spi1 and IRF8 are not expressed in HEK 293 cells. An additional 
panel displays ectopic expression of Spi1 in transfected HEK293. (B) Compariative Illustrations showing 
ectopic transfection of TRAF6 being used as a surrogate to induce the signaling, resembling LPS activation 
of monocytes. TRAF6 is a signal transducer, which acts downstream of the TLR4 receptor signaling 
pathway.  
 
Figure 36 shows that an IL1B reporter vector (XT-Luc) was potently up-regulated 
by Spi1 in combination with IRF8, a factor important for full IL1B activity in monocytes 
(Unlu et al., 2007) that is absent in HEK293, and dominant-positive TRAF6.  
 
 
90 
 
 
 
 
 
 
 
 
 
 
 
Figure 36. Spi1 is critical for IL1BXT-Luc reporter activity in HEK293 cells.  
Transcription factors associated with IL1B activation were ectopically transfected into HEK 293 cells 
together with IL1BXT Luciferase reporter. Binding of the ectopically transfected transcription factors 
causes activation of IL1BXT-luc reporter, which is represented as RLU (relative luciferase units). The 
effect of individual and combined transcription factors is compared to an empty vector pCDNA3.1 (vector) 
transfected samples. The dnSpi1 denotes a dominant negative Spi1 deletion protein lacking a critical N-
terminal trans-activation domain. The amount of the total transfected DNA was equal in all wells. The data 
are representative of three independent experiments.  
 
Spi1 function requires the integrity of its N-terminal TBP Binding Domain 
(TBD), as revealed in transient transfection using HeLa cells (Kominato et al., 1995). In 
agreement, ectopic expression of a dominant-negative Spi1 mutant (dn/Spi1), containing 
only the Spi1 DNA binding domain, reduced XT-Luc activity to background levels. 
Analysis of the endogenous IL1B mRNA by RT-PCR (Figure 37A, B) as well as qPCR 
(Figure 38A, B) in HEK293 transfected with the same factors supported the luciferase 
results as well as the critical role of Spi1 for IL1B induction (Figure 38).  
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Figure 37. Ectopically transfected transcription factors induce endogenous IL1B expression in HEK 
293 cells. 
Represented are the IL1B RT-PCR products isolated from HEK 293 cells that were ectopically transfected 
with combinations of transcription factors Spi1 and IRF8 (A) and Spi1and C/EBP (B) co-transfected with 
the LPS surrogate TRAF6. IL1B RT-PCR products analyzed by 3% agarose gel electrophoresis. The 
amount of the total transfected DNA is equal in all wells. The data are representative of three independent 
experiments. 
A      B 
 
 
 
 
 
 
 
Figure 38. Spi1, IRF8, and TRAF6 induce endogenous IL1B mRNA levels in HEK293 cells.  
(A) Shown are qPCR experiments detecting the IL1B mRNA in HEK293 cells that were ectopically 
transfected with wild type or dominant negative Spi1 and IRF8 co-transfected with the LPS surrogate 
TRAF6. Figure (B) shows IL1B mRNA levels in 293 cells transfected with above mentioned factors as well 
as a mutated IRF8 (IRF8Y211F). The data are normalized to the endogenous 18srRNA expression levels. 
The amount of the total transfected DNA is equal in all wells. The data are representative of three 
independent experiments. 
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Figure 39. Spi1 does not affect the endogenous levels of TNF mRNA in HEK293 cells.  
Represented is a qPCR analysis of the IL1B and TNF mRNA in HEK293 cells that were ectopically 
transfected with Spi1.  The data are normalized to the endogenous 18srRNA expression levels.  
 
 
 
 
 
 
Figure 40. Detection of ectopically expressed Spi1 mRNA in HEK293 cells.  
Shown is a 3% agarose gel of the Spi1 RT-PCR products from HEK293 cells transfected with various 
combinations of transcription factors and signaling molecules. Only HEK293 cells that express the 
ectopically transfected Spi1 reveal a positive RT-PCR band.    
 
The basal level of IL1B transcription in cells transfected only with Spi1 was 
radically increased by addition of IRF8 and TRAF6. IRF8 and TRAF6 alone (Figure 
38A) or in combination (Figure 38B) are insufficient for IL1B activation. Substitution of 
wild type with dn/Spi1 abolished IL1B expression. As Figure 38B demonstrates, IL1B 
message was reduced to a lesser degree in cells transfected with dominant negative IRF8 
(dn/IRF8), as previously reported (Unlu et al., 2007). In addition, TNF expression in Spi1 
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transfected HEK293 was not affected (Figure 39). Control RT-PCR data revealed that 
both, the wild type and dn/Spi1 are expressed in ectopically transfected 293 cells (Figure 
40).  
Since the N-terminal activation domain of Spi1 has been shown to directly 
interact with TBP (Hagemeier et al., 1993), I wondered whether Spi1 plays a role in 
recruitment of TBP to the IL1B promoter. To test this hypothesis, ChIP of IL1B was 
carried out in HEK293 transfected with either wild type or dn/Spi1 in combination with 
IRF8 and TRAF6. As shown in Figure 41, transfection of Spi1 and the auxiliary factors 
increased occupancy of TBP at IL1B TATA box. In agreement with an increase in IL1B 
transcription, I observed recruitment of Pol II to IL1B downstream of TSS, resembling a 
paused polymerase, as well as to the transcribed region of the gene, consistent with 
elongation. Enrichment signals for TBP and Pol II occupancy in HEK293 transfected 
with dn/Spi1 were dramatically reduced (Figure 41). Transfection-induced IL1B 
activation was also associated with depletion of promoter-proximal phased nucleosomes. 
Figure 42 shows that full length Spi1 in combination with TRAF6 and IRF8 is necessary 
for nucleosome depletion at the IL1B promoter. These data suggest that Spi1 plays a 
critical role at the IL1B, but not the TNF promoter. In addition to facilitating IL1B 
promoter accessibility (Marecki et al., 2004), the N-terminal TBD of Spi1 may play an 
additional role in the recruitment of the general transcription machinery via TBP. Its 
constitutive association at the promoter in a macrophage-restricted setting mediates IL1B 
transcriptional competency as well as stimulus-responsive selective activation. 
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Figure 41. The N-terminal domain of Spi1 is critical for the recruitment of TBP and Pol II to the 
endogenous IL1B promoter in HEK293 cells. 
Depicted are ChIP data for the ectopically expressed binding of Spi1 (top panel) along with the endogenous 
binding of TBP and Pol II. HEK 293 cells were transfected with an empty vector plasmid DNA (black line) 
or combination of wild type (red line) or mutant Spi1 (green line) co-transfected with IRF8 and TRAF6. 
The broader distribution of the TBP enrichment peak, as compared to the THP-1 experiments (Figure 17), 
is a result of a broader specificity for the antibody TFIID (TBP) sc-273, which was used for this 
experiment. 
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Figure 42. Spi1, co-transfected with IRF8 and TRAF6, mediates nucleosome eviction from the IL1B 
gene promoter.  
Shown are ChIP data for the spatial distribution of the core histone 3 (H3) along the IL1B gene promoter. 
HEK 293 cells were transfected with an empty vector plasmid DNA (black line), Spi1 alone (dotted blue 
line), or combination of wild type (red line) or mutant Spi1 (green line) co-transfected with IRF8 and 
TRAF6. Data used for generation of this figure are presented in Appendix F. 
 
C/EBP interaction with Spi1 mediates the LPS inducible induction of IL1B  
It has been postulated that the lineage-determining factor Spi1 facilitates 
formation of NFR, exposing binding sites for LPS-responsive transcription factors in 
activated monocytes (Natoli, 2012). Endotoxin dependent binding of NF-B, an IE 
transducer of numerous pro-inflammatory genes, has been shown to play an important 
role during coordinate induction of IL1B and TNF in monocytes (Hiscott et al., 1993); 
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(Collart et al., 1990). Our kinetic ChIP analyses revealed transient binding of NF-B to 
both genes as early as 30 minutes post LPS treatment (Figure 35).  
 
 
 
 
 
 
 
 
Figure 43. Kinetic binding of NF-B to IL1B and TNF in THP-1 cells.  
 
Shown is the ChIP analysis for the kinetics of NF-B binding to the IL1B and TNF gene promoters. The 
time points for LPS treatments are indicated above. Pre-treatment of the THP-1 cells with MG132 (1.5h 
MG) and BMS-345541 (1.5h IKK) inhibitors reduced the NF-B binding to both genes. The inhibitors 
were applied 2 hours prior to the 1.5-hour LPS stimulations of the THP-1 cells.  
 
Pre-treatment of THP-1 cells with NF-B-targeted inhibitors MG132 (proteasome 
inhibitor) and BMS-345541 (IB kinase inhibitor) diminished NF-B binding to both 
genes (Figure 43). Consistent with the decreased NF-B binding, the mRNA levels of 
both genes were significantly reduced. The mRNA expression was tested in both THP-1 
as well murine RAW cells (Figure 44, 47). The precise control of cell-permeable 
inhibitor addition to cells is suitable for conducting time sensitive kinetic experiments. 
Earlier studies used various in vitro assays in order to demonstrate the involvement of 
C/EBP during IL1B regulation (Auron and Webb, 1994; Tsukada et al., 1994).  
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Figure 44. NF-B is necessary for the LPS induction of IL1B and TNF genes in THP-1 cells. 
The 3% agarose gels reveal RT-PCR data for IL1B and TNF mRNA expression in THP-1 cells. DMSO, 
used to resuspend the MG132 inhibitor, has no effect on the IL1B and TNF gene activation. Inhibitor was 
applied 2 hours prior to LPS treatments (time points for LPS addition are indicated above the gel images).  
 
However, ChIP permits evaluation of the in vivo binding profile for C/EBP at 
IL1B and TNF regulatory regions in LPS stimulated cells.  Kinetic analysis illustrates 
LPS-mediated recruitment of C/EBP to the IL1B, but not to the TNF promoter (Figure 
45). Inhibitor U0126 was chosen in order to selectively target the MEK1/2 pathway that 
is involved in activation of C/EBP. LPS activated monocytes pre-treated with U0126 
revealed decreased IL1B transcription (Figure 46, 47), consistent with reduced C/EBP 
binding. TNF expression was unaffected by U0126 treatment (Figure 46, 47).  
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Figure 45. LPS inducible binding of C/EBP to IL1B in THP-1 cells.  
 
Shown is the ChIP analysis for the kinetics of C/EBP binding to the IL1B and TNF gene promoters. The 
time points for LPS treatments are indicated above. Pre-treatment of the THP-1 cells with the inhibitor 
U0126 for 2 hours was used in order to inhibit the C/EBP activity.  
 
 
 
 
Figure 46. C/EBP inhibition decreases IL1B mRNA expression in RAW264.7 cells.  
An RT-PCR analysis shows that selective targeting of MEK1/2 pathway leads to inhibition of IL1B and not 
TNF mRNA expression. RAW264.7 cells were pre-treated with various concentrations of U0126 for 2 
hours and mRNA levels were analyzed 1.5-hour post LPS treatment. The RT-PCR products were resolved 
using 3 % agarose gel.  
 
Transient transfection of the 293 cells was carried out in order to better define the 
role of these inducible transcription factors. NF-B and C/EBP were not effective IL1B 
inducers when transfected alone into 293 cells. 
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Figure 47. The effects of NF-B and C/EBP inhibition on IL1B and TNF mRNA expression in 
RAW264.7 and THP-1 cells.  
Shown are 3% agarose gels used for RT-PCR analysis of IL1B and TNF mRNA in RAW264.7 and THP-1 
cells. The cell cultures were pre-treated with NF-B (MG132) and C/EBP (U0126) inhibitors 2 hours 
prior to addition of LPS.   
 
 Significant activation of IL1B was observed when the factors were transfected in 
combination with Spi1. Co-expression with TRAF6 showed the strongest IL1BXT-Luc 
activity (Figure 48).  
 
 
 
 
 
 
Figure 48. NF-B and C/EBP cooperatively induce the ILBXT-Luc activity. 
Sown are relative luciferase data for IL1BXT-Luc reporter activity in HEK293 cells ectopically transfected 
with indicated factors. The effect of individual and combined transcription factors is compared to an empty 
vector pCDNA3.1 (Vector) transfected samples. The amount of the total transfected DNA is equal in all 
wells. The data are representative of three independent experiments.  
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Overexpression of an IB super repressor (IBSR), (Van Antwerp et al., 1996) 
considerably reduced, but did not completely abolish, IL1B activity in 293 cells 
transfected with Spi1, TRAF6, and C/EBP (Figure 49A).  This argues that in the 
absence of NF-B, transcription of IL1B may continue due to the presence of C/EBP. 
Experiments in RAW 264.7 cells further demonstrate that IBSR fully 
eliminates NF-B activity without completely inactivating IL1BXT-Luc (Figure 49B). 
A 
 
 
 
 
 
B 
 
 
 
 
 
Figure 49. Inhibition of NF-B activity does not completely abolish IL1BXT-Luc activity.  
(A) Ectopic expression of IκB super repressor (IκBSR) in HEK293 co-transfected with indicated 
factors. (B) IL1BXT-Luc and MHCB reporter activity in RAW264.7 transfected with IκB super 
repressor (IκBSR). The amount of the total transfected DNA is equal in all wells. The data are 
representative of three independent experiments.  
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In addition, titration of truncated, dn/C/EBP, (Tsukada et al., 1994) in 293 cells, 
confirmed a dose dependent inhibition of IL1B reporter expression (Figure 50). 
 
 
 
 
 
 
 
Figure 50. Ectopic transfection of dnC/EBP abolishes IL1BXT-Luc reporter activity in HEK293.  
Shown are relative luciferase data for IL1BXT-Luc reporter activity in HEK293 cells ectopically 
expressing wild type or indicated amounts of the dominant negative (dn) C/EBP co-transfected with Spi1 
and TRAF6. The amount of the total transfected DNA is equal in all wells. The empty vector pCDNA3.1 
was used to balance the amount DNA transfected across the samples. The data are representative of three 
independent experiments.  
 
 To further demonstrate the importance of NF-B and C/EBP for IL1B 
induction, RAW264.7 cells were transiently transfected with modified IL1BXT-Luc 
reporter harboring mutations within the essential NF-B (-300) and C/EBP (I-
Region/Enhancer) binding sites. As depicted in Figure 51, disrupted binding of these two 
factors severely reduced responsiveness of the IL1B reporter to LPS. Lastly, siRNA for 
NF-B and C/EBP in 293 cells revealed significant reduction of IL1BXT-Luc activity 
(Figure 52). IL1B expression was somewhat more sensitive to NF-B inhibition, as 
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compared to that of C/EBP. In agreement with our previous results, depletion of Spi1 
caused severe reduction of the IL1B reporter activity (Figure 52). 
 
 
 
 
 
 
 
Figure 51. Mutation of the critical C/EBP and NF-B binding sites reduces IL1BXT-Luc reporter 
activity.  
Shown are relative luciferase data for IL1BXT-Luc reporter activity in RAW264.7 cells ectopically 
transfected with the modified IL1BXT-Luc reporter harboring mutations within the essential NF-B (-300 
B) and C/EBP (I c/g) binding sites. The amount of the total transfected DNA is equal in all wells. 
 
 
 
 
 
 
 
Figure 52. siRNA mediated inhibition of C/EBP, NF-B, and Spi1 reduced IL1BXT-Luc reporter 
activity in HEK293.  
Shown are relative luciferase data for IL1BXT-Luc reporter activity in HEK293 cells ectopically expressing 
Spi1, IRF8, and/or TRAF6. The indicated transcription factors (C/EBP, NF-B, and Spi1) were depleted 
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using siRNA, which was transfected into HEK293 cells 24 hours prior to addition of Spi1, IRF8, and/or 
TRAF6.  
   The data presented here challenge the popular notion that NF-κB is the only 
critical factor affecting IL1B induction. It appears that NF-B and C/EBP cooperatively 
regulate LPS induced transcription of IL1B, while expression of TNF appears influenced 
primarily by NF-B.  
I next explored the relationship between the factors and the dynamics of the 
release of paused Pol II during transcription of IL1B and TNF. To address this question, 
P-TEFb ChIP was conducted on LPS stimulated THP-1 cells pre-treated with inhibitors 
targeting selected transcription factors. As shown in Figure 53, inhibition of NF-B 
resulted in significant depletion of P-TEFb recruitment to both genes. This observation is 
consistent with reports indicating that NF-B phosphorylated at serine 276 interacts with 
the active P-TEFb complex consisting of bromodomain protein 4 (BRD4) and cyclin-
dependent kinase 9 (CDK9) (Brasier et al., 2011). Signal dependent binding of NF-B in 
conjunction with histone acetylation (Hargreaves et al., 2009; Zippo et al., 2009) 
mediates the recruitment of BRD4 to the vicinity of gene promoters with the associated 
activity of CDK9, which induces the release of paused polymerases (Ai et al., 2011). TNF 
promoter ChIP revealed a rapid-transient recruitment of BRD4 within 30 minutes of LPS 
stimulation, whereas occupancy of BRD4 at the IL1B promoter was less prominent 
(Figure 54).  
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Figure 53. Effect of various inhibitors on P-TEFb binding to IL1B and TNF in THP-1 cells.  
Shown is a ChIP analysis of the P-TEFb binding in 1-hour stimulated THP-1 cells, pre-treated with the 
transcription factor inhibitors MG132 (blue bars) and U0126 (yellow bars), as well as the elongation factor 
P-TEFb inhibitor DRB (red bars). The data are indicative of at least 2 independent experiments.  
 
 
 
 
 
 
 
 
Figure 54. The effect of inhibitors on BRD4 binding to IL1B and TNF in THP-1 cells.  
Shown is the ChIP analysis for the kinetics of BRD4 binding to the IL1B and TNF gene promoters. The 
time points for LPS treatments are indicated above. The inhibitors (MG132, U0126, and DRB) were 
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applied 2 hours prior to the 1.5-hour LPS stimulations of the THP-1 cells. The data are indicative of at least 
2 independent experiments.  
My analysis revealed that binding of BRD4 to TNF is unaffected in DRB treated 
cells (Figure 54). In agreement, only slight inhibition of P-TEFb association at the TNF 
promoter was observed. In contrast, P-TEFb binding upon DRB treatment to IL1B was 
significantly depleted (Figure 53). Consistent with these results, both transcription 
(Figure 22, lower panels) and serine 2 CTD phosphorylation along the coding region  
(Figure 55) were affected more significantly for IL1B than for TNF.  
 
 
 
 
 
 
 
 
 
Figure 55. DRB differentially affects the S2P CTD Pol II occupancy on IL1B and TNF genes THP-1 
cells.  
Shown is a ChIP analysis of the S2P CTD Pol II occupancy in resting and 1-hour stimulated THP-1 cells. 
THP-1 cells were also pre-treated with the elongation factor P-TEFb inhibitor DRB (red bars) for 2 hours 
prior to LPS treatments.   
 
I argue that the differential association of P-TEFb on promoters for these genes in 
DRB treated cells is mediated by gene-specific BRD4 recruitment. P-TEFb recruitment to 
106 
 
IL1B seems to be less dependent upon BRD4 than TNF. In contrast, inhibition of C/EBP 
activation had a dramatic effect on P-TEFb binding to IL1B (Figure 53). This result 
suggests a possible novel role for C/EBP as an adaptor mediating the recruitment of 
P-TEFb to the IL1B promoter. As expected, only minor changes in P-TEFb occupancy at 
the TNF promoter was observed in U0126 exposed cells.  
 
 
Transcription Factor Mediated Looping Between the IL1B Distal Enhancer and 
Promoter 
Previous reports have identified distal far-upstream enhancers, positioned -3000 
bp upstream from the TSS for human and -2200 for mouse, critical for robust IL1B 
induction (Godambe et al., 1995; Shirakawa et al., 1993). Recent genome-wide studies in 
murine macrophages demonstrated that LPS responsive enhancers have common features 
marked by inducible p300 binding and H3K4me1 modification (Ghisletti et al., 2010; 
Heinz et al., 2010). This analysis of H3K4me1 revealed significant enrichment of this 
mark throughout the transcribed regions of IL1B and TNF, as well as at the -3000 bp 
upstream IL1B enhancer (Figure 56).  
 
 
 
 
 
 
Figure 56. H3K4me1 is present throughout IL1B and TNF in THP-1 cells.  
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ChIP data revealing H3K4me1 spatial-temporal distribution along the IL1B and TNF loci in resting (black 
line) 1 hour (red line) and 5 hour (green line) stimulated THP-1 cells. Averaged profiles derived from data 
shown in Appendix G. 
Chromosomal interactions between distal regulatory elements have been 
implicated in regulating gene expression (Dekker, 2006). The dynamic association of 
enhancers and promoters is often mediated by protein-protein and protein-DNA 
interactions among transcription factors and chromatin modifiers, ultimately leading to an 
enhanced transcription initiation (Deng et al., 2012). On the basis of in vitro studies, 
functional cooperation between enhancer bound C/EBP and promoter bound Spi1 DNA 
looping has previously been proposed as a mechanism for IL1B induction (Listman et al., 
2005; Yang et al., 2000). In collaboration with Dr. Kent Z.Q. Wang in our laboratory, I 
used chromatin conformation capture (3C) to examine LPS-dependent in vivo long-range 
chromosomal interactions between the IL1B enhancer and promoter. Figure 57B reveals 
LPS-dependent physical association between the IL1B distal and proximal regulatory 
elements.  
A 
 
 
B 
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Figure 57. LPS induced chromatin looping regulates IL1B expression.  
(A) Schematic representation of PCR primer pairs used for evaluating 3C ligation products. The four 
primers used for 3C analysis are indicated as 1’, 2, 3’, and 4 in the diagram.   
(B) 2% agarose gel was used for the PCR assessment of 3C ligation (restriction fragment) products from 
resting, 1 hour stimulated, and inhibitor treated THP-1 cells. One hour stimulated THP-1 cells were pre-
treated with the indicated transcription factor inhibitors MG132 (NF-B inhibitor), U0126 (C/EBP 
inhibitor) and additional C/EBP inhibitor SB 202190. 
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The NF-B and C/EBP inhibitors abolished LPS dependent chromosome loop 
formation (Figure 57B), transcription (Figure 44, 46, 47), nucleosome depletion (Figure 
28), and Pol II recruitment to the IL1B promoter (Figure 58).  
 
 
 
 
 
 
 
 
Figure 58. Effects of U0126 and MG132 on Pol II ChIP for IL1B and TNF.  
Shown is the ChIP analysis for the spatial-temporal distribution of Pol II throughout the IL1B and TNF 
genes. The time points for LPS treatments are indicated above. The inhibitors MG132 (NF-B inhibitor) 
and U0126 (C/EBP inhibitor) were applied 2 hours prior to the 1 hour LPS stimulations of the THP-1 
cells. The data are indicative of at least 2 independent experiments. 
 
My data reveal that the chromosome looping correlates with the binding of 
C/EBP to the enhancer and Spi1 to the promoter of Il1B. In addition to interacting with 
C/EBP, the DNA binding domain of Spi1 was shown to physically associate in vitro 
with NF-B (Nawarat Wara-aswapati and Philip E. Auron, unpublished data).  
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These data suggest that endotoxin activation of both C/EBP and NF-B may 
contribute to the dynamic juxtapositioning of the distal regulatory elements of IL1B by 
common association with two critical Spi1 binding sites previously mapped to the IL1B 
promoter (Kominato et al., 1995), resulting in the formation of a chromatin complex 
favorable for gene induction.  
Metabolic Effects on Transcriptional Regulation of Il1b and Tnf 
Since P-TEFb recruitment to IL1B, in contrast to TNF, appears to be less 
dependent upon BRD4 and more dependent upon C/EBP, other activation pathways for 
P-TEFb activation, by release from the inhibited 7SK/HEXIM1 complex, were 
considered. One of these is the possible involvement of PI3K/Akt, which has been 
reported to directly phosphorylate and inactivate HEXIM1 on the HIV promoter 
(Contreras et al., 2007). Figure 59 reveals that the PI3K inhibitor LY-294002 has a 
greater effect on P-TEFb recruitment to Il1b than to Tnf in LPS-treated RAW264.7 cells.  
 
 
 
 
 
 
 
 
 
Figure 59. The effect of PI3K inhibition on P-TEFb recruitment to Il1b in RAW264.7 cells.   
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Shown is ChIP analysis of P-TEFb binding to Il1b and Tnf in the presence of the PI3K inhibitor LY-
294002 in RAW264.7 cells. The inhibitor LY-294002 was applied 1 hour prior to LPS stimulations.  
 
Since increased synthesis of PI3K results in phosphorylation and activation of 
Akt/PKB, which can counteract the inhibitory effect of AMPK (low ATP) on mTorc1, I 
wondered whether there is a connection between Il1b gene activation and cellular 
metabolism. The non-metabolizable glucose analogue and hexokinase inhibitor 
2-deoxyglucose (2-DG) (Kang and Hwang, 2006) has been used to metabolically 
challenge cells by directly inhibiting glycolysis and ATP synthesis. I observed 
significantly higher levels of Pol II, S2P CTD, p-TEFb, and H3K36me3 on Tnf than on 
Il1b for 2-DG treated BMDM (Figure 60). In contrast to Il1b, the levels of S5P CTD at 
Tnf were not affected by 2DG. This is in agreement with experiments analyzing total Pol 
II levels, in which Il1b is more affected by treatment with 2DG (Figure 60). These 
results are consistent with a greater metabolic sensitivity for Il1b that may relate to the 
distinct mechanism of P-TEFb activation. Interestingly, ligand-mediated activation of 
both TLR and IL1R receptors not only induces IL1B transcription, but also directly 
recruits and activates PI3K (Marmiroli et al., 1998; Sarkar et al., 2004), consistent with 
the proposed role for PI3K/Akt in P-TEFb activated induction. 
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Figure 60. Distinct metabolic sensitivity for transcription elongation on Il1b and Tnf in murine bone 
marrow-derived monocytes.  
ChIP for factors related to Pol II initiation and elongation at Il1b and Tnf loci were measured in resting 
(black), 4h (light green) and 24h (light blue) LPS stimulated ex vivo-differentiated mouse BMDM. 
Enrichment profiles for Pol II, PTEFb, S2P CTD Pol II, S5P CTD Pol II, and H3K36me3 are shown. The 
BMDM were stimulated for indicated times with LPS ± 3 h pretreatment with 2-DG. The BMDM samples 
were provided by Luke O’ Neill, Trinity Collage of Dublin, Ireland.   
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HIF-1 plays an important role in regulation of the pro-inflammatory genes that 
are activatied in the TLR4 stimulated macrophages (Tannahill and O'Neill, 2011). Our 
analysis of the murine Ilib locus revealed a putative HRE element known to bind HIF-1 
(Kimura et al., 2000), which is adjacent to a previously reported NF-B site (Hiscott et 
al., 1993) (Figure 61).  
 
 
 
 
 
 
Figure 61. A schematic representation of putative HIF1 binding site upstream of the il1b gene 
promoter.   
Our group has located a putative HIF1 response element (HRE) binding sequence in the vicinity of the 
Il1b promoter, 360 bp upstream of the TSS. Shown is a comparison of human and mouse putative HIF-1 
binding site (Blue). The NF-B binding site  (red)  is positioned further downstream in the mouse as 
compared to a human IL1B. Additional experiments revealed that mutations in the HRE reduced the 
expression of the IL1B-luciferase reporter (Tannahill GM, 2013).  
 
ChIP analysis in BMDM revealed a delayed LPS inducible binding of HIF-1 to 
the putative murine HRE. The most prominent binding of HIF-1 to this promoter-
proximal regulatory site is observed at 12 and 24 hours. This experiment is part of a 
collaborative study that has additional evidence of HIF-1 involvement in Il1b gene 
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regulation (Tannahill GM, 2013).  Both 2DG and -KG reduced the HIF-1 binding to 
the HRE (Figure 62). The Tlr4 gene was used as a positive control (Kim et al., 2010).   
Our results reveal that HIF-1 is recruited to the Il1b promoter in LPS stimulated 
BMDM.  
 
 
 
 
 
 
 
 
 
Figure 62. HIF-1 is recruited to the Il1b and Tlr4 genes in LPS treated BMDM.  
ChIP for HIF-1 binding to the Il1b and Tlr4 proposed binding sites was measured in resting 4h, 12h, and 
24h LPS stimulated ex vivo-differentiated mouse BMDM. The BMDM were stimulated for indicated times 
with LPS and/or pre-treated for 3h with the non-metabolizable glucose analogue and hexokinase inhibitor 
2-deoxyglucose (2-DG) (Kang and Hwang, 2006), or the HIF1 inhibitor -ketoglutarate (-KG) (Gottlieb 
and Tomlinson, 2005). The BMDM samples were provided by Luke O’ Neill, Trinity Collage of Dublin, 
Ireland. 
 
IL-1 Family members are coordinately expressed in LPS stimulated THP-1 
monocytes. 
Since IL1B is a member of a family of 11 genes (Dinarello, 2009), I have 
investigated their LPS inducible expression in THP-1 monocytes. Our results reveal that 
9 gene members are coordinately expressed with the transcription levels peaking at 2 
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hours post LPS treatment. Interestingly, IL1F6 is constitutively expressed and LPS 
treatment dose not activate it. The expression of IL1F10 was not detected in THP-1 cells. 
Since IL1B is potently expressed in THP-1 cells, additional qPCR plots were generated in 
order to better resolve the kinetic expression pattern of the other inducible gene members 
(Figure 63).   
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Figure 63. Coordinate expression of the IL-1 gene family members.  
Shown are kinetic qPCR data for the various IL-1 family members in LPS stimulated THP-1 cells. LPS 
treatment time points are indicated. THP-1 cells were also pre-treated with the elongation factor P-TEFb 
inhibitor DRB (red bars) for 2 hours prior to LPS treatments. Since the expression of IL1B is extremely 
high, data presented in the bottom diagrams were re-scaled (100x, and 1000x) in order to visualize the 
expression kinetics for the less abundant family members.  
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DISCUSSION 
The induction of pro-inflammatory IE genes IL1B and TNF involves stringently 
regulated sequences of events triggered by TLR4 mediated detection of the LPS 
component of bacterial cell walls. My detailed kinetic analyses of the mRNA profiles of 
these immune genes provide novel insights into changes associated with their induction, 
switch down and reactivation. I was able to recapitulate previous observations (Fenton et 
al., 1988) demonstrating the expression pattern for IL1B and compare it to that of another 
coordinately expressed IE gene, TNF. Temporal profiles of steady-state mRNA levels 
revealed that both genes undergo a rapid transient induction, but differ in their 
transcriptional shut down. While TNF fits the transient IE gene model and is completely 
switched-off at 4 hours, elevated expression of IL1B continues for up to 24 hours post-
stimulation (Figure 6, 7). Because they code for potent inflammatory molecules, 
posttranscriptional degradation serves as a means to prevent their uncontrolled 
accumulation (Chen et al., 1994; Fenton et al., 1988). This explains the transient nature of 
these genes and argues that the observed sustained expression for IL1B is due to 
continuous transcription instead of message stabilization. Although IL1B sustained 
expression is relatively decreased, it is physiologically significant due to the potent 
biological activity of this cytokine (Dinarello, 2010) and the extremely high overall 
transcription level (Webb et al., 1985). Additionally, analysis of steady state mRNA 
levels in unstimulated THP-1 monocytes revealed the presence of low levels of un-
spliced TNF mRNA transcripts in comparison to undetectable IL1B. It has been 
hypothesized that low levels of constitutive transcription for primary response genes 
favors accessible chromatin and transcriptional competence important for their activation 
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(Hargreaves et al., 2009). Previous reports indicate that activation of IE genes resides at 
the level of pre-assembled components of transcription machinery at their promoters 
(Adelman et al., 2009; Hargreaves et al., 2009). Engaged, but paused, Pol II complexes 
and an euchromatic nucleosome architecture favors the immediate response to an 
appropriate stimulus causing transition into a state of processive elongation (Escoubet-
Lozach et al., 2011). Utilizing various molecular techniques I have analyzed the binding 
of specific signal-responsive transcription factors, general factors involved in Pol II 
regulation, and chromatin modifications in order to provide insights into mechanisms 
influencing the observed distinct expression profiles of IL1B and TNF. Although both 
mediators are classified as IE responders in TLR4-dependent stimulated cells, this study 
using human and murine monocytes reveals transcriptional and epigenetic differences 
during their expression cycle.  
 
In unstimulated cells, the TNF promoter proximal region contains a significant 
amount of pre-bound Pol II, which is consistent with studies in murine macrophages 
(Adelman et al., 2009; Escoubet-Lozach et al., 2011; Hargreaves et al., 2009). A 
collection of antibodies recognizing various modifications of the Pol II CTD was used to 
characterize the nature of this pre-assembled Pol II complex. ChIP analysis revealed the 
presence of S5P modified CTD co-localized with the observed total Pol II enrichment 
peak (Figure 17), which indicates that the observed Pol II has initiated transcription 
(Saunders et al., 2006), but paused nearly 57 bp beyond TSS. Additionally, I observed a 
high level of pre-bound TBP, a component necessary for accurate transcription initiation 
(Thomas and Chiang, 2006), at the expected TNF TATA box, further confirming the 
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presence of suitably engaged Pol II. I hypothesize that the pre-assembled components of 
the transcription machinery contribute to the low constitutive transcriptional leakiness of 
the TNF gene, keeping it primed for rapid activation. Under basal conditions, quiescent 
IL1B is more stringently regulated, containing only slight levels of Pol II engaged at the 
promoter and minimal TBP binding. I hypothesized that a recruitment of Pol II 
machinery to the IL1B promoter requires an additional step in the form of TLR4 
dependent recruitment of effector proteins and/or changes in chromatin accessibility. LPS 
stimulation triggered a transient increase of Pol II at the proposed TNF pause site as well 
as throughout the body of the gene (corresponding to elongating Pol II), but the levels of 
TBP did not significantly change. On the other hand, the induction of IL1B was primarily 
dependent on de novo recruitment of Pol II complexes, which paused shortly after 
resuming initiation in the vicinity of the TSS. As expected, binding of TBP paralleled the 
LPS dependent increase of Pol II at the IL1B locus. These results suggest a presence of 
two gene specific induction mechanisms with different rate-limiting properties. While the 
rate-limiting step in IL1B activation depends on de novo recruitment of Pol II, TNF 
induction is mediated by a release of existing promoter bound Pol II complexes. These 
differences likely contribute to the observed transcriptional delay for IL1B as measured 
by steady state mRNA and Pol II kinetic occupancy assays (Figure 8B). Analyses of 
NELF occupancy, a factor potentiating Pol II stalling (Core and Lis, 2008), revealed high 
binding levels at TNF in unstimulated cells followed by a decrease upon LPS treatment. 
An observed decline of NELF following stimulus is consistent with LPS dependent 
binding of P-TEFb, which induces phosphorylation of NELF (Gilmour, 2009) and 
alleviates the paused Pol II, transitioning it to elongation. At 5 hours post stimulation, 
121 
 
when message levels decline, P-TEFb is depleted from the promoter region and NELF 
occupancy returns to original levels, likely explaining gene shut down. In contrast to 
TNF, P-TEFb recruitment to IL1B is prolonged (although decreased) and present at 5 
hours post stimulation. This provides a plausible explanation for the delayed/sustained 
phase of IL1B expression as compared to that of TNF. The data argue for a kinetic 
interplay between positive (P-TEFb) and negative (NELF) pausing factors that may 
contribute to the differential post-induction decrease and shutdown of these two IE genes.  
A presence of paused polymerase, as indicated by increased enrichment signal at 
the promoter as compared to the structural gene, was detected at TNF and IL1B 
promoters in LPS stimulated monocytes. Interestingly, two paused Pol II complexes were 
detected at IL1B while only one primary complex was present at the TNF promoter 
(Figure 11). Analysis of the RNA intermediates revealed that the first Pol II peak at both 
genes was associated with short transcripts whose levels correlated with the temporal 
binding of Pol II and were selectively sensitive to inhibitor treatments (Figure 22). 
Global genome sequencing analysis revealed that such transcripts are actually nascent 
RNA intermediates emerging from stalling polymerases (Churchman and Weissman, 
2011). Detection of RNA intermediates was limited only to the regions beyond the TSS 
of both genes, which further confirmed that the observed transcripts are specific to 
processive polymerase, and not aberrant byproducts of cDNA synthesis. A total of five 
antibodies (Pol II, S5P CTD Pol II, NELF and P-TEFb) from independent ChIP 
experiments collectively revealed two pausing sites near the IL1B gene promoter. I 
hypothesize that the second Pol II complex at the IL1B locus represents a second paused 
polymerase. The progression of these complexes is delayed due to several plausible 
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factors. Since nucleosomes have been indicated in posing as a physical barrier to 
transcribing polymerases (Petesch and Lis, 2012), the presence of a downstream  +1 
positioned nucleosome might be responsible for halting Pol II movement. An additional 
explanation for the Pol II resting can stem from the presence of a long 5’ untranslated 
region (UTR) encompassing the first 505 bp of the IL1B gene. A recent study proposed a 
“complex interaction” model between core promoter elements and initiating and paused 
Pol II complexes, which can often accumulate at the intron-exon splicing junctions, as 
well as upstream of nucleosomes (Kwak et al., 2013). Such gathering of Pol II enzymes 
creates a dispersed Pol II enrichment signal at the transcription initiation site and beyond 
the TSS (Kwak et al., 2013). These observations further support the possibility that the 5’ 
UTR and +1 nucleosome present at the IL1B dictate pausing for transcribing/elongating 
Pol II. Additionally there are indications that the length of a 5’UTR can influence gene 
expression levels (Cenik et al., 2010). Since mRNA splicing can occur co-
transcriptionally (Goldstrohm et al., 2001), the augmented recruitment of splicing factors 
to the vicinity of 5’UTR can play a potential role in slowing down Pol II progression. In 
fact, studies suggest that a slower Pol II rate favors precise assembly of splicing factors 
for propter intron removal (de la Mata et al., 2010). I speculate that the second Pol II 
pause might serve as an additional regulatory checkpoint for ensuring proper IL1B 
transcription elongation.  
 
Here I show that LPS inducible binding of NF-B facilitates the recruitment of 
BRD4 and the subsequent recruitment of P-TEFb to human TNF. My data revealed that 
the inhibition of NF-B binding resulted in significant depletion of P-TEFb recruitment 
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to both genes (Figure 53). This observation is consistent with reports indicating that NF-
B phosphorylated at Serine 276 interacts with the active P-TEFb complex consisting of 
bromodomain protein 4 (BRD4) and cyclin-dependent kinase 9 (CDK9) (Brasier et al., 
2011). Signal dependent binding of NF-B in conjunction with histone acetylation 
(Hargreaves et al., 2009; Zippo et al., 2009) mediates the recruitment of BRD4 to the 
vicinity of gene promoters with the associated activity of CDK9, which induces the 
release of paused polymerases (Ai et al., 2011). Accordingly, I detected a transient 
recruitment of BRD4 to the TNF gene. ChIP enrichment for BRD4 at the IL1B promoter 
was much less prominent (Figure 54), suggesting that P-TEFb is not brought to the IL1B 
promoter independently of BRD4. Cell permeable inhibitor DRB was used in this study 
to block action of P-TEFb and show that blockade of this factor causes freezing of Pol II 
throughout the IL1B and TNF gene loci (Figure 17) and reduction of transcript 
accumulation (Figure 22). In addition to selectively inhibiting CDK9 activity (Baumli et 
al., 2010), DRB has been also shown to alleviate the inactive 7SK/HEXIM1 sequestered 
P-TEFb to an active BRD4-bound state (Biglione et al., 2007; Nguyen et al., 2001; Yik et 
al., 2003). In this way DRB increased recruitment of BRD4 and P-TEFb to the viral C 
promoter in Burkitt’s lymphoma cell lines (Palermo et al., 2011). My analysis revealed 
that binding of BRD4 to TNF is unaffected in DRB treated cells (Figure 54). In 
agreement, only slight inhibition of P-TEFb association at the TNF promoter was 
observed. In contrast, P-TEFb binding upon DRB treatment to IL1B was significantly 
depleted (Figure 53). Consistent with these results, both transcription (Figure 22, lower 
panels) and S2P CTD along the coding region  (Figure 55) were affected more 
significantly for IL1B than for TNF. I argue that the differential association of P-TEFb on 
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promoters for these genes in DRB treated cells is mediated by gene-specific BRD4 
recruitment. The LPS inducible P-TEFb binding to IL1B seems to be less dependent upon 
BRD4 than is TNF. In contrast, inhibition of C/EBP activation had a dramatic effect on 
P-TEFb binding to IL1B (Figure 53). This result indicates a likely novel role for C/EBP 
as an adaptor mediating the recruitment of P-TEFb to the IL1B promoter. As expected, 
only minor changes in P-TEFb occupancy at the TNF promoter were observed in cells 
depleted of active C/EBP by the usage of selective inhibitor U0126 (Figure 53). 
Additionally, I argue that PI3K/Akt mediated rescue of P-TEFb from inhibitory 
7SK/HEXIM1 complex can selectively contribute to the elongation state of Il1b in 
murine macrophages (Figure 59). Since it has been shown that a metabolic imbalance of 
cells affects the PI3K/Akt transduction pathway, a disruption of glucose availability in 
stimulated BMDMs caused selective inhibition of Il1b transcription as compared to TNF, 
as shown in Figure 60.   
Macrophage metabolism plays an important role regulating transcriptional control 
of pro-inflammatory cytokines (Murdoch et al., 2005). My collaborative work with the 
laboratory of Professor Luke O’Neill using murine macrophages revealed a novel role of 
the oxygen sensing effector protein HIF1 in controlling Il1b transcription. Our group 
has located a putative HIF1 response element (HRE) binding sequence in the vicinity of 
the Il1b promoter, 360 bp upstream of the TSS (Tannahill GM, 2013). TLR4 dependent 
stimulation of macrophages caused HIF1 binding to the HRE at 4 h with increasing 
levels by 24 hours (Figure 62). The functional role of HIF1 was further established by 
the addition of cell permeable -KG, which abolished its LPS mediated recruitment to 
Il1b. It was shown that -KG induces HIF1 degradation (Gottlieb and Tomlinson, 
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2005) and prevents its nuclear translocation. Additionally, treatment of cells with the 
non-metabolizable glucose analogue 2DG (Kang and Hwang, 2006) also prevented 
HIF1 binding. I postulate that 2DG mediated disruption of macrophage metabolism and 
down-regulated activity of HIF1, leading to decreased Il1b expression. The Tnf gene 
was not susceptible to 2DG treatment, as revealed by mRNA and Pol II ChIP analysis 
(Figure 62). My kinetic ChIP analysis suggests that HIF1 recruitment to Il1b is delayed 
and follows the binding of the rapidly induced factors NF-B and C/EBP. I speculate 
that HIF1 plays a role in mediating the sustained phase of il1b expression. This is 
distinct from Tnf, which lacks a putative HRE in the vicinity of its promoter. Figure 64 
summarizes the key observations and differences in the regulation of the il1b and tnf gene 
transcription.  
Previous reports argued that il1b and tnf genes are refractory to reactivation due to 
a plethora of intrinsic immuno-protective mechanisms commonly recognized as 
endotoxin tolerance (Chan et al., 2005; Foster and Medzhitov, 2009). Endotoxin 
tolerance results in a decreased responsiveness of certain rapidly-induced monocyte 
genes to repeated LPS stimulation. In agreement with the previous studies, our data 
indicate that once activated, TNF cannot be re-expressed upon secondary stimulation 
(Figure 7). In addition, the reduced responsiveness of TNF cannot be reversed with 
increased concentration of LPS used for subsequent reactivation (Figure 13). Prior 
attempts to explain this phenomenon by transcription suppression have failed to note that 
expression profiles for these genes are highly transient. If transcription following 
secondary stimulation is not analyzed within a short time frame, the re-stimulation 
properties can be overlooked. The endotoxin tolerance study by Foster et al., (Hargreaves 
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et al., 2009) used ten-fold less secondary LPS stimulant than the primary dose. I argue 
that the usage of inconsistent doses of secondary LPS throughout the studies skews the 
experimental results. In my reactivation experiments, cell cultures were re-stimulated 
with an equal dose of secondary LPS.  
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Figure 64. Metabolic and TLR4 dependent pathways differentially regulate transcription of il1b and 
tnf.  Several findings of this work are represented in this figure. Depicted are LPS sensing TLR4 pathways 
leading to activation, nuclear translocation and DNA binding of the transcription factors NF-B and 
C/EBP. While the induction of TNF is primarily dependent on NF-B, IL1B requires both, NF-B and 
C/EBP for its proper activation. This figure illustrates the connections between the metabolic pathways 
and the regulation of HIF1 stability. Hypoxia, LPS treatments, and various metabolites affect the presence 
of HIF1 in cells. These conditions inhibit the action of the enzyme prolyl hydroxylase (PHD), which 
causes the ubiquitin-mediated degradation of HIF-1. Stabilized HIF-1 translocates into nucleus where it 
binds to the hypoxia-response element located upstream of il1b.  
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In addition, the washing of cells between primary and secondary endotoxin 
challenge may result in experimental variability and induce physiological stress to the 
highly sensitive cells. Here I show that the washing of cells caused dramatic reduction of 
IL1B expression (Figure 27). In contrast, IL1B transcription is not desensitized in un-
washed cell cultures (Figure 7, 13). This indicates that secondary LPS addition after 
washing cells is ineffective and does not properly activate the transduction pathway 
leading to transcriptional induction of IL1B. I hypothesize that washing cells with PBS or 
media lacking fetal bovine serum (FBS) prior to secondary challenge may deprive the 
cells of important soluble components such as LPS-binding protein (LPB) and CD14 that 
are vital for proper TLR4 signaling (Aderem and Ulevitch, 2000).  
My data provide evidence that IE gene promoters contained paused pol II 
complexes after their initial transient transcription burst for up to 25 hours. This work 
reveals that upon secondary stimulation, P-TEFb is re-recruited to the IL1B promoter, 
resulting in the resumption and maintenance of transcriptional elongation by Pol II. This 
is in contrast to tolerized TNF, in which secondary recruitment of P-TEFb and S2P are 
absent (Figure 24, 25). As described in the introduction, P-TEFb mediated 
phosphorylation of serine 2 within the CTD of elongating Pol II promotes recruitment of 
various splicing factors to ensure proper nascent mRNA processing (Buratowski, 2003; 
Egloff and Murphy, 2008). The fact that P-TEFb is recruited to IL1B and not TNF during 
secondary LPS exposures, prompted me to examine the integrity of transcripts produced 
in reactivated THP-1 cells. The analysis of a random primer (instead of polyA) generated 
cDNA products, which revealed a minor increase of TNF mRNA in secondary stimulated 
monocytes (Figure 26). These messages likely represent incompletely processed primary 
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TNF transcripts that are generated by the low levels of P-TEFb-deficient transcribing Pol 
II. I propose that the gene specific recruitment of P-TEFb serves as a regulatory step 
mediating the escape form endotoxin tolerance. This mechanism ensures proper IL1B 
mRNA polyadenylation and processing, which is deficient during the re-stimulation of 
the TNF gene. My results indicate that the low levels of sustained IL1B expression may 
maintain the gene sufficiently competent for secondary re-induction. Collectively my 
mRNA and protein analyses argue that secondary induction of IL1B is a physiologically 
significant phenomenon that further distinguishes it from TNF. 
Nucleosome positioning is intimately linked to gene regulation by controlling the 
accessibility of gene promoter sequences (Bai and Morozov, 2010). I have mapped the 
nucleosome distribution (as measured by the spatial distribution of the nucleosome core 
protein histone 3) in the vicinity of the promoter proximal regions as well as the temporal 
changes associated with their LPS inducible evictions and differential re-assembly at the 
end of the transient vs. sustained phase of TNF and IL1B transcription, respectively. My 
data reveal a cell type specific NFR located upstream of the strongly phased +1 
nucleosome at both genes (Figure 28). Analysis of HEK 293 cells, which do not 
transcribe IL1B, revealed the presence of a highly phased -1 nucleosome within the NFR 
that was also prominent in the inhibitor treated THP-1 cells (Figure 28). Transfection of 
Spi1 with IRF8 and TRAF6 (acting as an LPS surrogate) induces displacement of this -1 
nucleosome. I hypothesize that this highly transiently positioned nucleosome serves as a 
control checkpoint mediating a cell type and stimulus selective accession of transcription 
machinery to the IL1B core promoter elements. Inhibition of transcription factor 
activation/recruitment to gene promoters in THP-1 cells similarly abolished LPS induced 
130 
 
nucleosome clearance in a gene specific manner (Figure 58). While the inhibition of NF-
B had a pronounced effect on both IL1B and TNF, C/EBP inhibition only affected 
nucleosomes on the IL1B promoter (Figure 58).  This data provides a functional link 
between transcription factor activation and nucleosome clearance from these LPS-
induced IE promoters. A temporary clash between the -1 nucleosome and Pol II binding 
could be responsible for the quiescent behavior of IL1B prior to its induction, 
contributing to the observed transcriptional delay, as shown by Pol II ChIP and mRNA 
kinetic studies (Figure 12).  Spatial-temporal analysis of the chromatin modifications 
throughout the TNF and IL1B IE gene loci reveal monocyte-specific presence of low 
levels of active marks such as H3K4me3 and H3K9ac in unstimulated cells. To my 
surprise these marks did not significantly increase in 1 hour stimulated cells but 
significant elevation in their enrichment was observed during the switch off of the genes 
(Figure 30, 33). I argue that high levels of transcribing polymerases impede nucleosome 
deposition and modification throughout the structural part of the genes. At the end of the 
transient transcription burst, nucleosomes are re-deposited into their original positions 
and become subject to histone modifiers. Strikingly, my results revealed an opposite 
pattern for H3K9me1 levels distributed throughout IL1B and TNF in resting monocytes. 
This mark was high in resting cells, but rapidly lost following LPS treatment and 
remained low even during transcriptional shut-down. A methylated H3K9 commonly 
associated with repressive heterochromatin, was shown to play a role in repression of 
selected inflammatory genes in monocytes (Kouzarides, 2007; Saccani and Natoli, 2002). 
Although the antibody used in the study by Saccani and Natoli was not specific enough to 
distinguish mono-, di-, or tri-methylated lysine at H3, based on the spatial distribution of 
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H3K9me1 in IL1B non-expressing cell lines (Figure 33), the H3K9me1 can likely be the 
methylated form inducing a facultative heterochromatin. I observed that LPS replaced 
repressive H3K9Me1 marks with transcriptionally permissive acetylation, likely 
contributing to the enhanced gene expression of IL1B and TNF (Gomes and Espinosa, 
2010).  It is possible that monocytes package the IL1B and TNF genes with H3K9Me1 to 
form repressed, but poised, chromatin conformations for keeping these IE genes from 
exhibiting high transcriptional activity. The inhibitory mark H3K27me3 was virtually 
absent from the gene loci, but its level was increased in cell types that do not transcribe 
these IE genes (Figure 30, 33). TNF in Hut 102 cells reveals significant levels of both 
H3K4me3 and H3K27me3, the so-called “bivalent” mark (Akkers et al., 2009), indicative 
of developmental, rather than transient IE induction, possibly responsible for the 
constitutive expression of this gene in these HTLV-1 infected malignant T cells (Figure 
30, 33). HEK293 cells do not show positive indicators for either gene, exhibiting non-
bivalent inhibitory H3K27me3 on both. The inhibitory H3K27me3 extends throughout 
the entirety of both genes, but appears to be more focused over the coding region of TNF. 
In contrast, IL1B reveals a greater level of H3K27me3 far upstream over the potent LPS 
enhancer near -3000, which binds C/EBP (Shirakawa et al., 1993) (Figure 30, 33). The 
suppressive effect of the polycomb group proteins mediated by H3K27me3 directed 
transcriptional silencing is reversed by the H3K27 specific demethylase JMJD3 during 
macrophage inflammatory responses (De Santa et al., 2007). Loss of this repressive 
chromatin mark in Drosophila and embryonic stem cells, was shown to result in an 
increase in H3K27 acetylation, which was mediated by the histone acetyltransferase 
(HAT) activity of p300 and CBP (Pasini et al., 2010; Tie et al., 2009). My observations 
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of depleted levels of H3K27Me3 in THP-1 cells encouraged us to examine the kinetic 
changes in H3K27Ac deposition and binding patterns of p300 on IL1B and TNF. As 
revealed in Figure 31, acetylation at lysine 27 was associated with LPS-dependent 
increase at the -2 nucleosomes, while, transient decrease in H3K27Ac on downstream 
nucleosomes was observed. In agreement with these changes, p300 was transiently 
recruited upstream of IL1B and TNF promoters by LPS (Figure 32).  
My data reveal that the cell type restricted expression of IL1B is due to the 
presence of the monocyte-specific differentiation factor Spi1/PU.1 (Spi1), which binds 
constitutively to the IL1B promoter and enhancer in resting THP-1 (Figure 34) and 
poises the gene for induction. The question of macrophage and B-cell restricted gene 
regulation was addressed in previous studies that revealed that Spi1 binding corresponded 
to nucleosome depleted regions and mediated local deposition of H3K4me1 as novel LPS 
inducible enhancer mark (Ghisletti et al., 2010; Heinz et al., 2010). Additionally my data 
show that Spi1 plays a critical role in poising and proper activation of the IL1B gene 
promoter. As a pioneer factor, Spi1 may have a unique capability of binding a properly 
oriented nucleosome wrapped DNA (Ghisletti et al., 2010; Smale, 2010). I provided 
evidence that ectopic expression of Spi1 facilitated the recruitment of TBP via its N-
terminal binding domain (Figure 41, 42). In resting monocyes the IL1B core promoter 
was depleted of nucleosomes, but TBP recruitment was evident only upon LPS activation 
(Figure 41). I postulate that the binding of Spi1 is necessary, but insufficient, for LPS-
mediated induction in THP-1 cells, as well as in HEK293 cells for which Spi1 in the 
absence of surrogate stimulation (co-expression of IRF8 and TRAF6) does not cause 
strong nucleosome clearance (Figure 42). I hypothesize that stimulation-dependent 
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binding of NF-B and C/EBP to the DNA loop-mediated proximity of constitutively 
bound Spi1, facilitates induction of IL1B via nucleosome remodeling. Both of these 
factors bind transiently to specific promoter sites and cooperatively regulate the Pol II 
dynamics at this gene (Figure 43, 45, 58). The Spi1-mediated nucleosome eviction is 
especially true for the -1 nucleosome, which appears to occlude TSS-proximal binding of 
TBP (Figure 28, 42). This contrasts with TNF, in which the -1 nucleosome resides 
further upstream, permitting TBP access (Figure 28). The mechanism by which this 
occurs could depend upon the observed stimulation-dependent recruitment of p300 
histone acetyltransferase (Figure 32) and the SNF2/BRG1 SWI/SNF chromatin 
remodeling enzyme (Figure 29) by activated transcription factors. Both NF-B (Hottiger 
et al., 1998; Tando et al., 2010) C/EBP (Kowenz-Leutz and Leutz, 1999; Mink et al., 
1997) as well as HIF-1 (Kenneth et al., 2009) have been reported to directly recruit both 
SWI/SNF remodelers and p300 histone acetyltransferases. This would enable the 
nucleosome clearance required for Spi1-assisted recruitment of TBP to TATA box DNA. 
Regardless, as suggested by ectopic expression in HEK293 cells (Figure 42), 
nucleosome remodeling depends upon the integrity of the Spi1 N-terminal domain in 
concert with the activation of transcription factors, and appears to be necessary for TBP 
recruitment. These cooperative associations likely facilitate the subsequent assembly of 
the paused Pol II complex and regulate its release by P-TEFb in order to transition into 
productive transcription elongation. The presence of highly paused and rapidly 
transcribed Pol II further enhances the open promoter by competing with nucleosome re-
deposition (Core and Lis, 2009). 
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Additionally, it was postulated that CK2 kinase may play a role as an LPS 
inducible switch for Spi1 bound at the IL1B enhancer mediating IRF4 recruitment and 
facilitating gene expression (Liang et al., 2006). In search of a mechanism for Spi1 
activation, I hypothesized that CK2 can potentially act as an LPS dependent Spi1 
activator mediating recruitment of TBP. My ChIP analyses did not reveal the presence of 
LPS induced CK2 binding to the IL1B promoter. On the other hand, Spi1-mediated TBP 
recruitment can be suppressed by an inhibitory factor in unstimulated monocytes. For 
example, Translocated in liposarcoma (TLS), an RNA binding protein was shown to bind 
Spi1 in vivo and suppress its transcriptional activity (Hallier et al., 1998). RNA binding 
properties of TLS were also associated with noncoding RNA (ncRNA) mediated 
CBP/p300 inhibition and transcriptional repression of CCDN1 gene upon DNA damage 
signals (Wang et al., 2008). I speculate a potential role for TLS or a similar inhibitory 
factor acting as a repressive control switch at the IL1B promoter that is alleviated in a 
TLR4 dependent manner. Interestingly a preliminary screen for LPS induced non-coding 
RNA in THP-1 cells has revealed a candidate ncRNA with TLS binding site (J. Adamik, 
unpublished data) located at approximately -300 bp upstream of the IL1B TSS.  Figure 
65 depicts a model for Spi1 mediated TBP recruitment as well as the recruitment of two 
paused complexes to IL1B gene. 
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Figure 65. Model depicting a possible spatial configuration for the IL1B promoter sequence (Courtesy 
of Philip E. Auron). 
The model is derived from the published X-ray structures using coordinates provide by the RCSB Protein 
Data Bank (PDB): Spi1 DNA binding ETS domain (1PUE) (Kodandapani, R., et al., 1996); TBP (1YTB) 
(Kim, J.L., et al, 1993); and Pol II (1EN0) (Gnatt et al., 2001) DNA complexes. The PDB coordinates for 
the above structures were positioned as independent DNA complexes in pseudo 3D-space, connected by 
appropriate lengths (Kominato et al., 1995) of B-form DNA in accordance with the theoretical interaction 
reported for the association of Pol II with TBP (Bushnell et al., 2004) using RasMac 2.7.3 molecular 
graphics visualization software. The location and nature of the cartoon extension representing the amino, 
extra-ETS domain, regions of the Spi1 transactivation region is positioned in contact with TBP, as 
supported by an earlier report (Hagemeier et al., 1993). 
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Finally I show, that the orchestrated recruitment of transcription factors to the 
IL1B enhancer and promoter mediate their proximal chromosomal interactions (Figure 
57). Since NF-B and C/EBP are necessary for induction of the chromatin loop and 
were shown to physically associate with Spi1 (Nawarat Wara-aswapati and Philip E. 
Auron, unpublished data) (Listman et al., 2005), I postulate that such interactions may 
mediate activation of Spi1 leading to recruitment of TBP and Pol II, resulting in gene 
transcription. Interestingly, the 3C results demonstrating the existence of a chromatin 
loop, consistently revealed the prevalence of one PCR product in unstimulated 
monocytes. This PCR band, which represents a primary recombination product in 
unstimulated monocytes, suggests the possibility of a preferred conformational proximity 
for the upstream and downstream IL1B sequences prior to LPS induction (Figure 57). 
Such preformed chromatin architecture has been observed for cells at specific 
developmental stages (Meaburn and Misteli, 2007).  
Analysis of the temporal expression patterns of the IL-1 family genes revealed 
LPS inducible coordinate expression for several members (Figure 63).  The most 
abundantly expressed member of the cytokine family in the THP-1 cells is IL1B. IL1A, 
IL1RN, IL18, and IL33 are expressed with similar kinetics, but their expression is weaker. 
The last group of genes including: IL1F7, IL1F9, IL1F8, and IL1F5 also correspond to 
the LPS inducible expression pattern with the weakest detection level. I did not detect 
expression of IL1F10 in LPS stimulated THP-1 monocytes. Interestingly, IL1F6 was 
constitutively expressed and its expression was actually down regulated with LPS 
treatment. A significant level of constitutive expression was also detected for the 
members: IL1RN, IL18, and ILF7. Strikingly DRB treatment abolished the expression of 
137 
 
all the members suggesting that they are transcribed by paused polymerases and that 
P-TEFb recruitment serves as an important regulatory step during their activation. 
Members that were constitutively active were reduced to a lesser degree when treated 
with DRB. This suggests that some of their accumulated transcripts produced in resting 
cells were present even though their LPS inducible transcription was halted due to the 
lack of active P-TEFb. The eukaryotic nucleus is organized into distinct transcriptional 
units that contain preformed Pol II machineries called “transcription factories”. These 
clusters of transcription complexes and coactivators bound to gene regulatory regions are 
tethered via DNA loops and are able to efficiently coordinate the transcription of several 
gene units (Cook, 2010; Papantonis and Cook, 2010). Since the IL-1 family members are 
transcribed with similar kinetics, and most of them are located on the same chromosome, 
it is possible that they are part of a larger 3D transcription unit.  I speculate that the 3kb 
chromatin loop observed for the IL1B promoter and enhancer might be part of a higher 
order clustered gene family conformation. The paused polymerases present at the 
promoters might likely facilitate the assembly of chromatin domains that bring the gene 
members into proximity.  
In summary, IL1B and TNF differ in the initial state of their promoters in 
unstimulated cells. Strikingly, during maximal initial expression (1 h) the chromatin 
architecture of the two genes looks quite similar. However, at later times (5 h) distinct 
new architectures are established, resulting in the tolerizing of TNF. Importantly, I 
observe that the IL1B and TNF genes, although both dependent upon the activation of 
NF-B, reveal numerous distinctions (Figure 66) that may be reflective of the known 
differences that exist for the cell source range and functions of their gene products. IL-1 
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expression is known to be more restricted to monocytes than is TNF (Kronke et al., 
1988), likely dependent upon the requirement for Spi1. The distinct functions of the two 
proteins is supported by the recent advent of specific therapeutic blockers, which reveal 
that there are various diseases in which protein blockade results in asymmetric efficacy, 
and occasionally asymmetric contraindication (Argiles et al., 2011; Dinarello, 2011a, b). 
Consequently, it is reasonable that such functional differences might require a degree of 
differential regulation for two similar, but non-identical immune effectors.    
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Figure 66. Proposed Mechanism for LPS mediated induction of IL1B and TNF in monocytes 
(Courtesy of Philip E. Auron).  
(A) Summary of ChIP kinetics for some key features of IL1B and TNF in THP-1 monocytes. Pol II, TBP 
and Spi1 are as indicated. Histone modifications at specific locations detailed in the text are labeled. Key 
nucleosomes are designated by position relative to the TSS (-2, -1, +1). (B) Models for IL1B and TNF gene 
regulation. Red text highlights important distinctions between the two genes along the induction kinetic. 
Nucleosomes are marked with stars (acetylation) and spheres (trimethylation) representative of significant 
increases in modification. Darkly colored nucleosomes are phased and likely to be less dynamic, and 
suggestive of impediments to gene expression. The indicated locations of Pol II are represented by various 
levels of intensity, reflecting the relative degree of proposed dwelling on DNA. Arrowheads on Pol II 
represent the relative efficiency of elongation, as indicated by the length of the associated dotted line.  
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SUMMARY OF NOVEL FINDINGS AND FUTURE STUDIES 
This dissertation significantly contributes to the understanding of immediate early 
(IE) gene induction for two important Toll-like receptor 4 (TLR4)-dependent genes 
coding for TNF and IL-1. The study of these two immune mediators can be applied to 
variety of other stimulus dependent immune and developmental genes. IE genes are 
almost instantaneously induced in response to extracellular signaling events due to gene 
poising, a process that is thought to involve a paused, pre-recruited, RNA polymerase 
(Pol II). I have investigated the mechanisms of endotoxin induction, shutdown and 
endotoxin tolerance for these genes. This study reveals major distinctions that correlate 
with the transcription factor requirement, dynamics of Pol II pausing, nucleosomal 
promoter architecture, and epigenetic signatures. The kinetic approach used in this study 
focuses on the resting state, prompt transcription, and transient shut down, providing a 
novel understanding of the temporal resolution of IE gene regulation. An additional issue 
relates to the study of endotoxin tolerance, the phenomenon of desensitization of a TLR4 
signal following recent prior signaling. Here I show that the IE genes have low levels of 
paused polymerases for up to 24 hours post-stimulation even though their transcription is 
absent or minimal. Upon subsequent LPS exposure, the tolerized TNF gene remains in a 
paused state, while the IL1B gene resumes additional transcription due to influence of the 
a positive elongation kinase P-TEFb. This work presents novel connections between 
macrophage metabolism and the regulation of pro-inflammatory genes. My additional 
collaborative study in murine macrophages revealed a novel role for the oxygen sensing 
effector protein HIF1 in controlling Il1b transcription. The genes coding for TNF and 
IL-1 have long been associated with the activation of the NF-B transcription factor, 
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which is important for vigorous expression. As a consequence of this dependence and 
similar expression kinetics, the assumption has been that these genes are similarly 
regulated. I have observed that in contrast to TNF, IL1B is continually expressed for long 
periods and is significantly less susceptible to the phenomenon of endotoxin tolerance, 
while being more sensitive to the metabolic state of the cell. My study shows that 
although I observe pre-induced TNF to behave as what is now classically referred to as a 
poised gene, by virtue of the presence of a paused pre-recruited RNA polymerase (Pol II) 
and TATA binding protein (TBP), the resting IL1B gene is generally devoid of TBP and 
Pol II. Therefore, IL1B appears to behave as a poised IE gene in the absence of the 
hallmarks that have been suggested to be critical for immediate early induction. I provide 
novel results demonstrating that complete NF-B inhibition decreases, but does not 
completely eliminate, IL1B transcription, supporting the involvement of other factors 
which may play a critical role in regulating this potent gene. These include C/EBP for 
the IL-1 gene (IL1B), and the realization that the various new specific therapeutic 
blockers of TNF and IL-1 often generate distinct asymmetric effects and 
contraindications, supporting evidence in favor of distinct roles and mechanisms for these 
molecules in homeostasis and disease. My C/EBP and NF-B inhibition experiments 
suggest a distinct functional linkage between the transcription factors and the recruitment 
of Pol II machinery as well as the P-TEFb to these IE genes. A detailed analysis of the 
spatial-temporal distribution of chromatin marks in resting monocytes reveals that 
epigenetic modifications such as H3K4me3 and H3K9ac often resemble chromatin 
patterns of an actively transcribed gene as compared to non-monocytic cell lines. Here I 
provide new evidence that the differential gene shutdown observed between the two IE 
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genes is reflected by the nature of their chromatin modifications following the initial 
phase of rapid-transient transcription. My results extend beyond the previously reported 
Spi-1/Pu.1-mediated opening of pro-inflammatory gene enhancers and suggest a novel 
role for this pioneer factor at selected IE gene promoters. The findings of this work 
provide a new model for IL1B gene activation, which involves an inducible 
enhanceosome-like chromosomal looping and dynamic nucleosome transactions 
mediated by inducible transcription factor interactions.  
Since the mechanisms associated with IL1B and TNF gene regulation are highly 
dynamic and complex, several unanswered questions remain to be determined. As 
hypothesized in the discussion, the mechanism responsible for the IE nature of the IL1B 
gene is intriguing because this functionally “poised” gene fails to exhibit the classic 
hallmark of a significant amount of pre-bound/paused Pol II, as has been suggested by 
others (Gilchrist et al., 2008; Guenther et al., 2007; Kininis et al., 2009; Muse et al., 
2007; Rahl et al., 2010; Zeitlinger et al., 2007). However, many aspects of the IL1B 
promoter such as nucleosome phasing, constitutive transcription factor assembly, and the 
transcriptionally permissive chromatin marks suggest that the promoter is competent for 
Pol II recruitment. Yet, one striking difference is the relatively low level of pre-recruited 
TBP. In this way, IL1B does not fit the model of an IE gene. One possible explanation is 
that the IL1B promoter is repressed in a way that prevents its basal transcription, perhaps 
inhibiting TBP recruitment by Spi1. Studies of the CCND1 gene, which codes for cyclin 
D1, revealed that its expression is down-regulated by an upstream series of inhibitory 
ncRNA. By associating with the TLS (translocated in liposarcoma) protein, ncRNA 
mediates inhibition of p300 histone acetyltransferase activity leading to gene shut down 
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(Wang et al., 2008). Interestingly, my preliminary examination of the IL1B locus revealed 
a TLS consensus binding sequence approximately 300 bp upstream of the IL1B promoter. 
An initial screening using non-quantitative PCR revealed the existence of several LPS-
dependent upstream transcripts, one of which contained the TLS consensus. A kinetic 
ChIP, targeting TLS in resting and LPS treated monocytes could provide an indication of 
its connection to the expressed ncRNA. If a correlation is observed, siRNA mediated 
inhibition of TLS can be performed in order to reverse the potential repressive effects 
associated with its association with the IL1B promoter. Additionally, one could design 
antisense probes (shRNA) to target potential ncRNA, potentially abolishing any ncRNA 
inhibitory effect on IL1B in resting monocytes, observing whether this results a low level 
of basal transcription and Pol II recruitment to the gene.  
Another issue beyond the initial repression of IL1B is the mechanism responsible 
for both its extended expression and re-induction (i.e., its resistance to endotoxin 
tolerance). One possible model is that this process is dependent upon a distinct means of 
late induction. An obvious candidate is the late LPS-dependent binding of HIF-1 
(Figure 61). This could be approached by using inhibitors, such as -ketoglutarate or 
HIF-1 siRNA to determine whether a reduction in HIF-1 can convert the induction 
profile for IL1B into one similar to that exhibited by TNF. 
The IL-1 family gene members are another topic that could be explored in more 
detail. Since the preliminary mRNA study revealed a coordinate expression of these 
genes (Figure 64), Pol II ChIP can be performed to further define the transcriptional 
responsiveness of these genes. Additionally, a circularized chromatin conformation 
capture (4C) (Simonis et al., 2007), which can capture numerous long-range interactions, 
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could be a valuable tool to assess physical chromatin associations at the 180 kbp IL-1 
gene family locus on human chromosome 2.    
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Appendix A. Comparison of IL1B and TNF Transcription in Monocytes 
Steady-state mRNA kinetics for IL1B and TNF transcripts in LPS stimulated THP-1, RAW264.7, and 
hPBMCs. Transcript levels were normalized to beta 2-microtubulin (B2M), and then as ratio of amount in 
resting vs. LPS-treated cells. The mRNA dlevels for primary LPS challenge are represented as black bars. 
White bars show transcript levels following re-stimulation. 
162 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix B. Pol II occupancy at the il1b and tnf loci. 
Pol II ChIP throughout the IL1B and TNF loci in resting (black bars), 1h (red bars), and 5h (yellow bars) 
LPS stimulated THP-1, RAW264.7, and hPBMC cells. Vertical gray bars locate the positions of important 
gene landmarks. Numbers at the bottom of the figures denote positions relative to the TSS. These include 
TATA box and the canonical Pol II pause position (approximately 30 bp upstream and 50 bp downsteam of 
TSS, respectively).  
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Appendix C. Distribution of factors relevant to differential transcriptional regulation. 
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ChIP for factors related to Pol II initiation and elongation at IL1B and TNF loci in THP-1 cells were 
measured at distinct time points in resting (black bars), 1h (red bars) and 5h (yellow bars) LPS stimulated 
THP-1 cells. Enrichment profiles for TBP, S5P CTD Pol II, S2P CTD Pol II, NELF, P-TEFb and Pol II 
(using alternative 8WG16 antibody) are shown. A purple bars in the 8WG16 (bottom panels) experiment 
represents a 1-hour time point, in which THP-1 cells were pre-treated with the P-TEFb inhibitor 5,6-
dichloro-1-beta-D-ribofuranosylbenzimidazol (DRB) prior to stimulation with LPS.  
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Appendix D. Average profiles of factors relevant to differential transcriptional regulation in LPS-
treated RAW264.7 cells. 
ChIP for factors related to Pol II initiation and elongation at Il1b and Tnf loci in RAW264.7 cells were 
measured at distinct time points in resting (black bars), 1h (red bars) and 5h (yellow bars) LPS stimulated 
THP-1, cells. Enrichment profiles for Pol II, TBP, S5P CTD Pol II, S2P CTD Pol II, NELF, P-TEFb and 
Pol II (using alternative 8WG16 antibody) are shown. A purple dotted line in the 8WG16 (bottom panels) 
experiment represents a 1-hour time point, in which RAW264.7 cells were pre-treated with the P-TEFb 
inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazol (DRB) prior to stimulation with LPS.  
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Appendix E. ChIP re-stimulation experiments at 25 hours.  
ChIP for S2P CTD Pol II, NELF, P-TEFb, and Pol II at the IL1B and TNF during secondary LPS 
stimulation of THP-1 cells. The white and gray bars denote ChIP data for primary LPS challenge harvested 
at 13 and 25 hours post simulation respectively. The pink and light green bars show ChIP data for THP-1 
cells that were initially treated for 13 and 24 hours respectively with LPS, and subjected to a re-stimulation 
for an hour prior to their fixation and harvest. Equal dosage of LPS (1 g/ml) was used in both, primary 
and secondary stimulation experiments.  
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Appendix F. Nucleosome positioning dynamics during IL1B and TNF induction. 
In the top panels are depicted spatial and kinetic histone 3 (H3) ChIP data for IL1B and TNF in resting 
(black bars), 1h (red bars), and 5h (yellow bars) stimulated THP-1 cells. The blue bars represent H3 ChIP 
for THP-1 cells pre-treated with the NF-B inhibitor MG132 and the orange bars denote the U0126 
(C/EBPβ inhibitor) treated THP-1 cell samples. The middle panels reveal H3 occupancy throughout the 
IL1B and TNF in Hut102 and HEK293 cells. Bottom panel indicates H3 ChIP for 293 cells transfected with 
indicated transcription factors.  
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Appendix G. Summary of the histone modification ChIP profiles for IL1B and TNF in THP-1, HEK 
293, Hut102, and MG63 cells. 
Illustrated are the summary profiles comparing nucleosome modifications for resting (black bars), 1h (red 
bars), and 5h (yellow bars) LPS-treated human THP-1 cells with untreated HEK293 pre-neuronal cells 
(purple bars), Hut102 cutaneous T lymphocytes (light blue bars), and MG63 osteoblastic cells (orange 
bars). Depicted are spatial and kinetic ChIP profiles for Pol II, H3K36me3, H3k4me3, H3K9ac, and 
H3K27me3, H3K9me1, H3K27ac, and H3K4me1 for IL1B and TNF. All panels are similarly scaled with 
respect to spatial distribution along each gene, permitting comparative localization.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
